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Abstract 
Aim: The aim of the study was to evaluate the operative and post-operative 
complications, and outcomes of laparoscopic surgery using the Harmonic scalpel in 
patients with recto-vaginal endometriosis (RVE). Furthermore, pre-operative work up 
and referral patterns were evaluated. 
Design:  Retrospective chart review.  
Method:  Following ethical (BREC No. BE O42/11) and hospital regulatory approvals, a 
retrospective chart review  of the hospital case records of all patients who underwent 
laparoscopic surgery for RVE using the Harmonic scalpel from January 2004 to 
December 2010 was performed. All relevant clinical information was captured on 
structured data sheets which were kept confidential and used strictly for the purposes of 
the audit.  
 
Results: The case records of 105 women who had laparoscopic surgery for endometriosis 
between January 2004 to December 2010 were identified Thirty-three (31.4%) patients 
with RVE were treated using the Harmonic scalpel as the main energy source. From this 
cohort of patients, there was one case which required conversion to laparotomy for rectal 
injury which was successfully repaired; one case required re-laparoscopy for suspected 
intra-operative bleeding and another required cystoscopy and double J stenting due to 
anuria of 21 hours post- surgery. 
The mean hospital stay was 4 days. 76% of women had improvement of pain after 
surgical intervention and concomitant adjuvant medical therapy was used in 30.3%. 
 
Conclusion: The usage of Harmonic scalpel as the energy source in the management of 
RVE appears to be safe and the morbidity is comparable to other energy sources reported 
in literature. 
 
Key words: Endometriosis, Recto-vaginal, Surgery, Complications 
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Chapter 1 
 Introduction 
 
Endometriosis is a common benign gynaecological disease that leads to significant 
health problems for women in their reproductive ages. It is defined as presence and 
proliferation of endometrial-like tissue outside the uterine cavity
 
and is estimated to 
occur in 10-15% of women in their reproductive ages
(1, 2)
. Endometriotic lesions occur 
commonly in the pelvic side walls, ovaries, pouch of Douglas and the utero-vesical 
fold
(3)
. There are three forms of endometriosis in the pelvis, viz., peritoneal, ovarian and 
deep infiltrating endometriosis (DIE) of which recto-vaginal endometriosis is the most 
common
(4, 5)
. In DIE, the endometriotic implants invade the retroperitoneal space for a 
distance of 5 mm or greater and the lesions involve the pouch of Douglas, utero-sacral 
ligaments and the recto-vaginal septum
(6)
. 
 
Recto-vaginal endometriosis (RVE) is a severe form of DIE and its pathophysiology is 
still an area of controversy
(7)
. The endometriotic nodules have a dominant fibrotic 
component within the connective tissue between the anterior-rectal wall and the vagina; 
and the endometriotic infiltration may also occur between the vagina, cervix, posterior 
aspect of the uterus and the rectum
(8)
.  
 
The depth of endometriotic nodule invasion into the pouch of Douglas is variable, i.e., 
the nodules can invade through into the vagina or cervix, and can be visualized on 
speculum examination. The presence of endometriotic lesions in the vagina or cervix 
confirm the presence of RVE, which occurs in approximately 31.4% of patients with 
endometriosis
(3)
.  
 
Recto-vaginal endometriosis is strongly associated with dyschezia, painful 
menstruation, dyspareunia, extreme fatigue and chronic pelvic pain. These symptoms 
adversely affect the quality of life of women affected
(3)
. 
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Endometriosis can be suspected by its typical clinical presentation, clinical findings and 
its well-known sonographic features, but laparoscopy remains the gold standard for 
diagnosis. 
 
It has been reported that medical therapy is effective in the treatment of superficial 
endometriosis but has less effect on RVE
(9)
.  However, combined oral hormonal 
contraceptives, gonadotrophin-releasing hormone analogues (GnRHa) and progestogens 
may cause temporary relief of pain symptoms for a short period of time. 
 
Laparoscopic surgery of RVE is often regarded as the gold standard. It involves various 
energy sources for the excision of deep endometriosis. This form of surgery is 
challenging and associated with morbidity of which conversion to laparotomy is not 
infrequent. The surgery is technically difficult, requires skills gained through intensive 
training and is mostly considered for patients with severe incapacitating symptoms. The 
choice of surgery depends on the surgical skills available and the reproductive needs of 
the woman
(9)
. Many authors, advocate complete tissue separation and excision of the 
diseased tissues, however, there is no consensus among gynaecologists on the best 
approach to achieve this goal and there is variety of approaches suggested
(10, 11)
.  
 
Conventional surgery utilizes electrosurgical energy which is associated with the risk of 
bowel and a ureteric injury since the pathology is in close proximity to these structures. 
The Harmonic scalpel facilitates dissection using ultrasonic energy (mechanical) with 
minimal thermal injury and allows for rapid tissue healing. However there is scant 
literature on complications and outcomes on the usage of the Harmonic scalpel for the 
treatment of RVE. 
 
The main objective of this study was to evaluate operative and post-operative 
complications and outcomes of laparoscopic surgery using the Harmonic scalpel in 
patients with RVE. Furthermore, referral patterns and pre-operative workup were 
evaluated. 
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Chapter 2 Background and Literature Review 
2.1 Epidemiology of Endometriosis 
2.1.1 Prevalence 
 
Endometriosis is mostly found in women of child-bearing age, commonly between the 
ages of 25 to 29 years, but it can also occur beyond the average age if there is 
associated infertility rather than pelvic pain alone
(12)
. Also, this disease condition can be 
found in adolescent women with an estimated 50% of women under the age of 20 years 
with chronic pelvic pain or dyspareunia, having the disease
(13)
. 
 
The prevalence of endometriosis varies and this depends on the population where the 
studies are conducted
(3)
.  About 1-7% of women undergoing bilateral tubal sterilization, 
12-32% of women in the reproductive age group undergoing laparoscopy for pelvic 
pain and approximately 20-40% of women with infertility are affected
(14)
.  Emmanuel  
et al., reported that endometriosis occurs in 10-15% of women in their reproductive 
years
(2)
. Studies have shown that there is a lower incidence rate of endometriosis in 
African-American women compared to white Americans, while the incidence rate is 
higher among Asian American women when compared to white women
(15)
. 
 
It is estimated that 55% of DIE occurs in the pouch of Douglas, 35% in the utero-sacral 
ligaments and 11% in the utero-vesical fold. The overall prevalence of RVE varies from 
5–10% of women with endometriosis and has been noted to be increasingly recognised 
as a different clinical syndrome from the superficial forms of the disease 
(3, 16)
. 
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2.1.2 Risk factors 
 
Age 
Virtually all women in their reproductive ages are potentially vulnerable to develop 
endometriosis but appropriate immune competency  mostly eradicates such lesions in a 
timely fashion, preventing its clinical sequelae
(17)
. Pelvic endometriosis is not often 
diagnosed before the age of menarche and decreases after the age of menopause. The 
studies done in women below the age of fifty years reported that the frequency of the 
endometriosis rises with age until menopause, however recent studies have not 
supported these findings
(18, 19)
 . 
 
This discrepancy can be explained by the different selection criteria in various studies. 
Furthermore, in recent years more young women undergo laparoscopy rather than 
laparotomy for infertility and the diagnoses of endometriosis is made as a coincidental 
finding.  
 
Social Class and Race 
 
Women of higher social class have been reported to have higher incidence of 
endometriosis
(20, 21)
.  These findings could be explained by the affordability the women 
of higher social class have over lower social classes for pelvic pain or infertility and 
hence the diagnosis of endometriosis. Kyama et al., showed that African-American 
women have lower incidence of endometriosis than white Americans, whereas Asian 
Americans have higher incidence of endometriosis than white women
(15)
. The same 
disparity might account for the higher incidence of the disease in white women 
compared to other races.  
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Menstruation, Reproductive factors and Contraception 
 
The English literature is scanty on the association between woman‟s menstrual history 
and risk of developing pelvic endometriosis. Epidemiological studies conducted in the 
United States of America (USA) and Italy reported that women with early menarche, 
and those with heavy menstrual periods are at greater risk of developing pelvic 
endometriosis
(20, 21). This could be related to the „retrograde hypothesis‟(22).  Also, the 
risk of developing the disease is inversely related to parity
(19, 23)
. However, the available 
data have not revealed any link between first pregnancy age or spontaneous abortion to 
the risk of developing endometriosis
(21, 24)
. 
 
Treatment of endometriosis with oral contraceptives (OC) has not been shown to 
completely eradicate endometriosis because when treatment stops, the atrophic forms of 
ectopic endometrial implants are reactivated
(25)
. Some authors have hypothesized that 
use of OC could increase the risk of severe disease since they temporarily suppress 
endometriosis. Sangi-Haghpeykar et al., reported that the risk of the disease was 
reduced among current OC users
(26)
. However, data is conflicting regarding the link 
between the OC use and the risk developing endometriosis. One large cohort study 
reported that, the rate of developing endometriosis was low among the current or recent 
users of OC than those women who were never put on them (relative risk of 0.4, 95%, 
confidence interval 0.2–0.7), there was a higher risk of developing the disease in   
women who discontinued OC much earlier (2–4 years) with risk ratio of 1.8, 95% CI 
1.0–3.1)(27).  
 
Heredity and Family history of endometriosis 
 
There is evidence indicating that combinations of genetic, hormonal, immunological 
and anatomical factors have an impact on the formation and development of the ectopic 
foci of endometriosis. The genetic predisposition is evidenced by a 7% chance of 
developing the disease if it is present in a first-degree relative and women with positive 
family history might have a more severe form of the disease
(28, 29)
.  
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Simpson et al., reported a six-fold risk for developing endometriosis to sisters of 
women  with the disease, while Moen et al., found an odds ratio of  7.2 (p< 0.05) for 
developing endometriosis for a first-degree relative with the disease
(30, 31)
. Furthermore, 
Moen (1994), showed that six sisters of eight monozygotic twins with endometriosis 
also developed the disease
(32)
. 
 
Lifestyle: smoking, alcohol and exercise 
 
Some authors have suggested an inverse relationship between heavy smokers and the 
risk of developing endometriosis. Cramer et al., found a decreased risk of the disease in 
smokers
(21)
. The anti-estrogenic effect of smoking is the recognized explanation. 
However, Missmer et al., observed an increased risk of endometriosis with increased 
number of cigarettes currently smoked per day to women with no infertility 
problems
(14)
. 
 
A moderate ingestion of alcohol leads to increased serum levels of estrogens and hence 
the risk of developing endometriosis and an increased consumption of saturated fats 
leads to high risk of other benign or malignant diseases in gynaecology while regular 
physical activity might be associated with lower levels of estrogens and lower risk of 
developing endometriosis. However data is scanty
(33-35)
. 
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2.2 Pathogenesis, Morphology and Molecular Bases 
 
The pathogenesis of endometriosis is mostly dependent on ovarian steroids, in 
particular estrogen and progesterone. The ectopic endometrium has been shown to 
produce estrogen in increased amounts. The abnormal expression of the aromatase 
enzyme in the ectopic endometrium allows the conversion of androgen hormones to 
estrogen
(36)
. In the pelvis, there are three separate forms of endometriosis viz., 
peritoneal, ovarian and DIE
(4, 5)
.  
 
In DIE, the endometriotic implants penetrate into the retroperitoneal space for a 
distance of 5 mm or more and may extend into the pouch of Douglas, uterosacral 
ligaments and the recto-vaginal septum
(6)
. RVE is a severe form of DIE
(7)
. It 
encompasses endometriotic invasion between the vagina, cervix, posterior aspect of the 
uterus and the rectum. The depth of invasion into the vagina and cervix varies and if the 
invasion is severe, the endometriotic lesions can be easily visualized on clinical 
speculum examination and this is an ominous sign indicating the presence of RVE
(3)
. 
These lesions may also penetrate through the different layers of the rectal wall, even 
penetrating through into the rectal mucosa
(3)
. There are three classes of recto-vaginal 
endometriotic nodules, viz., (i) Type I-lesions occur in the recto-vaginal septum, (ii) 
Type II- lesions occur in the posterior vaginal fornix and (iii) Type III- lesions resemble 
the shape of an hour-glass. The prevalence of these nodules are 10, 58 and 32% 
respectively
(37)
.  
 
Several theories with regard to its pathogenesis have been postulated: 
 
Sampson’s theory:  
Transplantation and Implantation theory postulates that viable fragments of 
endometrium are shed at the time of menstruation and passed through the fallopian 
tubes and become implanted on the peritoneal surfaces and grow into endometriotic 
lesions, a phenomena of retrograde menstruation
(22)
. In general, retrograde menstruation 
is reported to occur in 70% to 90% of women; however, it is a common finding in 
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women with endometriosis compared to those who do not have the disease
(38, 39)
. 
Studies in animal models have shown that when endometrial cells are deposited in the 
peritoneal cavity, the lesions formed are similar to those found in women with 
endometriosis. Also, it has been demonstrated that when menstrual blood is placed in 
the peritoneum of disease free animals, ectopic lesions similar to endometriosis 
develop
(40)
.  
 
Coelomic Metaplasia Theory:  
 
Iwanoff and Meyer are well recognized as the founders and supporters of the above 
mentioned theory. The theory postulates that endometriosis develops from metaplasia 
of the cells lining the pelvic peritoneum
(41)
. This hypothesis is based on embryologic 
studies that illustrated that mullerian ducts, germinal epithelium of the ovary and the 
pelvic peritoneum have the same embryologic precursor. The findings that 
endometriosis is rare in males is recognized as the proof of coelomic metaplasia theory.  
However, both men in the study were on estrogen therapy
(42, 43)
. 
 
Lymphatic and Vascular Metastasis Theory: 
 
This theory suggests that distant endometriotic lesions are established by the 
lymphogenous spread of viable endometrial cells. Halban reported that endometriosis 
could emerge in the retro-peritoneum and in sites not directly opposed to peritoneum
(44)
. 
Although retrograde menstruation seems almost certain to be involved in the 
pathogenesis of the disease, the theory does not explain the full spectrum of the disease, 
as the endometrial implants are occasionally found in other sites such as the lung or in 
the nose. Endometriosis does occur in men who are taking large doses of oestrogen but 
the occurrence is rare
(45)
. This follows that the theories of coelomic metaplasia and 
Halban‟s theory better explains the aetiology of endometriosis rather than retrograde 
menstruation. 
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Immunological Theory: 
 
The alterations in both humoral and cellular immunity have been described in the 
pathogenesis of endometriosis. It has been reported that the natural killer cell activity is 
reduced in women with endometriosis, and that there is an abnormal expression of 
macrophages that both secrete cytokines and growth factors involved in promoting the 
proliferation of the ectopic endometrium
(28)
. 
 
Exogenous oestrogen replacement therapy is suggested to play a role in the 
development of endometriosis in post-menopausal women and this disease is estimated 
to occur between 2-5 % of this age group
(46, 47)
. Some authors suggest that RVE has 
different pathophysiological process to peritoneal endometriosis and should be called 
recto-vaginal adenomyosis or recto-vaginal adenomyomata
(4, 5)
. However, Vercellin et 
al., indicate that RVE may be a different manifestation of endometriosis with a single 
origin i.e. regurgitated endometrial cells. The endometrial cells implant into the most 
dependent area of the pelvis, the posterior cul-de sac (Pouch of Douglas). The recto-
sigmoid colon acts as an anatomic shelter, covering endometrial cells and preventing 
them from being cleared by the usual process within the peritoneum cavity. They also 
hypothesized that bleeding of the intraperitoneal endometriotic papules may trigger 
inflammatory response in the pouch of Douglas leading to adhesion formation between 
anterior rectal wall and posterior vaginal fornix peritoneal surfaces; and the ectopic 
implants become nodular because of reactive proliferation of fibroblasts eventually 
becoming isolated from the rest of the pelvis by adhesion formation
(48)
. 
 
Congenital anomalies like obstructive müllerian duct of the cervix or vagina account for 
the majority of girls under the age of 17 years with the disease of endometriosis
(49)
. 
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Morphology 
 
The appearance of endometriotic lesion varies, it may appear as a superficial “powder-
burn” or “gunshot” lesions on the ovaries, serosal surface and peritoneum. They may 
also appear as atypical or “subtle” lesions, as well as red implants (petechial, vesicular, 
polypoid, haemorrhagic or red flame-like) and as serous or clear vesicles. Moreover, the 
lesions may appear as white plaques or scarring, or as yellowish brown peritoneal 
discoloration of the peritoneum and the type and severity of symptoms is related to the 
depth of endometriotic peritoneum infiltration
(50)
. The nodules often contain a thick 
fluid-like tar and the cysts are often densely adherent to the peritoneum of the ovarian 
fossa. The adjacent fibrotic tissue may involve the tubes and bowel
(51)
. Deeply 
infiltrating endometriotic nodules penetrate to a depth of 5 mm or more below the 
peritoneum and may extend into the utero-sacral ligaments, vagina, bowel, bladder, or 
ureters
(6)
. The nodule and surrounding fibrosis may infiltrate the rectal or vaginal walls 
with the POD being obliterated by dense adhesions, and the endometriotic nodules may 
develop in the uterosacral ligaments
(52)
. When the endometriotic nodule extends 
laterally, the ureter and the parametrium may be invaded. 
 
 
Molecular Basis 
 
Several proteins were proposed and the role they play in the development of 
endometriosis evaluated. Some of the proteins investigated were HOXA10 and 
Annexin-1. The HOXA10 protein is a member of the homeobox gene family that has a 
substantial role in formation of endometriosis. Kim et al., evaluated the expression of 
HOXA10 in the eutopic endometrium of baboons with induced endometriosis 
(53)
. They 
observed that HOXA10 mRNA was reduced after 3, 6, 12, and 16 months of disease, 
and these findings showed statistical significance at 12 and16 months. Also, the 
HOXA10 protein levels were found to be low in both epithelial and stromal cells of the 
endometrium. Furthermore, they also observed a decrease in the expression of integrin-
b3 (usually up-regulated by HOXA10), whereas EMX2 was increased (a gene that is 
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inhibited by HOXA10). In their study, they also analysed the methylation patterns of 
the HOXA10 gene in both the diseased and disease free animals (controls). It was 
observed that the F1 region on the promoter was significantly methylated in the 
diseased animals compared to controls and this was suggested to account for the 
decrease in HOXA10 expression 
(53)
. 
 
In the same study, the role of HOXA10 in IGFBP1 expression was also studied using 
human endometrial stromal cells. They found that the overexpression of HOXA10 in 
human endometrial stromal cells led to a decrease of IGFBP1 mRNA. However, when 
HOXA10 was under-expressed; IGFBP1 mRNA was elevated, even in the presence of 
H1db cAMP. The authors concluded that their data demonstrated that the HOXA10 
gene has a negative influence on IGFBP1 expression in decidualizing cells. Thus, a 
decrease in HOXA10 levels may play a role in the altered uterine environment 
associated with endometriosis
(53)
. 
 
The other protein evaluated was Annexin-I. This protein belongs to the Annexin family 
of Ca
2+
-dependent phospholipid-binding proteins. Li et al., 2008, detected the 
expression of Annexin-1 in peritoneal fluids of women with endometriosis. These 
findings emerged when they evaluated the expression of Annexin-1 in eutopic 
endometrium of women with endometriosis and in those without the disease
(54)
. 
Immunohistochemistry demonstrated that Annexin-1 protein was expressed throughout 
the menstrual cycle mainly in endometrial glandular cells. This protein was detected in 
the peritoneal fluids of women with endometriosis. These authors concluded that 
Annexin-1 is over expressed in eutopic endometrium and is detectable in the peritoneal 
fluids of women with the disease, and this is thought to play a part in the pathogenesis 
of endometriosis
(54)
. 
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2.3 Classification of Pelvic Endometriosis 
 
 
Staging of endometriosis is a way of describing how mild or severe the condition is. 
The stage of the disease is determined via laparoscope by inspecting the uterus, fallopian 
tubes, and ovaries, and by inspecting the entire abdomen for the presence or absence of 
adhesions. Several classification schemes to assist in describing the anatomic location 
and severity of endometriosis at surgery have been described.  
 
Acosta et al., proposed a classification system of pelvic endometriosis that divided the 
disease based on surgical findings into mild, moderate, and severe categories (see Box 
1)
(55)
. The categories included the site of lesions, presence or absence of adhesions, and 
the presence or absence of tissue scarring or retraction. Also, the presence of small 
endometriomas (< 2 cm) or the presence of minimal peritubal or periovarian adhesions 
distinguished a moderate form of the disease from a mild form of the disease. However, 
many physicians believed that this classification system has several disadvantages, 
because of the arbitrariness of the staging and its inability to distinguish between 
unilateral or bilateral disease. 
 
Box1.  A proposed classification of pelvic endometriosis
(55)
 
Mild        1. Scattered, fresh lesions (ie, implants not associated with scarring or retraction of the     
                   peritoneum) in the anterior or posterior cul-de-sac or pelvic peritoneum. 
2. Rare surface implant on ovary, with no endometrioma, without surface scarring and retraction, or 
                     small endometrioma 
3. No peritubular adhesions. 
 
Moderate 1. Endometriosis involving one or both ovaries, with several surface lesions, with scarring and   
                         retraction,  or  small endometriomata.  
                 2. Minimal periovarian adhesions associated with ovarian lesions described. 
                 3. Minimal peritubular adhesions associated with ovarian lesions described. 
                 4. Superficial implants in the anterior and/or posterior cul-de-sac with scarring and retraction. Some   
                         adhesions, but not sigmoid invasion. 
 
Severe      1.  Endometriosis involving one or both ovaries with endometrioma > 2 x 2 cm (usually both). 
                   2.  One or both ovaries bound down by adhesions associated with endometriosis, with or without  
  tubal adhesions to ovaries.     
                  3. One or both tubes bound down or obstructed by endometriosis; associated adhesions or lesions. 
                  4. Obliteration of the cul-de-sac from adhesions or lesions associated with endometriosis. 
                  5. Thickening of the uterosacral ligaments and cul-de-sac lesions from invasive endometriosis with   
                      obliteration of the cul-de-sac. 
                  6. Significant bowel or urinary tract involvement.              
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Kistner et al., developed a different staging system that moved from early peritoneal 
implants to ovarian involvement to tubo-ovarian involvement to dissemination 
throughout the pelvis (see Box 2)
(56)
. The strong emphasis in this group was that the 
impaired tubo-ovarian mobility was the major cause of infertility. 
 
 
Box 2 Kistner‟s classification of endometriosis(56) 
Stage I      Areas of endometriosis are present on the posterior pelvic peritoneum (cul-de-sac, uterosacral   
                  ligaments) or on the surface of the broad ligaments but do not exceed 5 mm in diameter. Avascular   
                  adhesions may   involve the tubes, but the fimbriae are free. The ovaries may show a few avascular    
                  adhesions, but there is no ovarian fixation. The surfaces of the bowel and the appendix are normal. 
 
Stage IIA   Areas of endometriosis are present on the posterior pelvic  peritoneum (cul-de-sac, uterosacral  
                   ligaments)  and the broad ligaments but do not exceed 5 mm in diameter. Avascular adhesions may  
                   involve the tubes, but the   fimbriae are free. Ovarian involvement by endometriosis has been  
                    subclassified as follow: IIA-1: Endometrial cyst or surface is 5 cm or less 
         IIA-2: Endometrial cyst or surface is over 5 cm. 
        IIA-3: Ruptured endometrioma; the bowel and the appendix are normal.       
Stage IIB   The posterior leaf of the broad ligament is covered by adherent ovarian tissue. The tubes present  
                  adhesions not removable by endoscopic procedures. The fimbriae are free. The ovaries are fixed to  
                  the  broad ligament and show areas of endometriosis over 5 mm in diameter. The cul-de-sac presents  
                  multiple implants, but there is no adherent bowel nor is the uterus in fixed position. The bowel and  
                  the appendix are normal. 
 
Stage III     The posterior leaf of the broad ligament may be covered by adherent tube or ovary. The tubal  
                    fimbriae  are covered by adhesions. The ovaries are adherent to the broad ligament, and tube may or  
                    may not  show surface endometriosis or endometriomas. The cul-de-sac shows multiple areas of  
                    endometriosis, but there is no evidence of adherent bowel or uterine fixation. The bowel and the 
                    appendix are normal   .  
Stage IV    Endometriosis involves the bladder serosa, and the uterus is in fixed, third-degree retroversion. The  
                   cul-de-sac is covered by adherent bowel or is obliterated by the fixed uterus. The bowel is adherent  
                   to the cul-de-sac, uterosacral ligaments, or uterine corpus. The appendix may be involved by the  
                  endometriotic  process. 
 
Despite several modifications, none of the classification systems of endometriosis 
received widespread acceptance and use before the year 1978, and this led to the design 
and publication of another classification system of endometriosis in 1979 by the 
American Fertility Society (AFS) (Fig 1)
(57)
. In this classification scheme endometriosis 
was stratified into mild, moderate, severe, and extensive disease and used a weighted 
point score that included assessment of the extent of endometriosis (two-dimensional) 
and presence of adhesions in the peritoneum, ovaries, and tubes. It also allowed for 
assessment of unilateral versus bilateral disease.  
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Fig.1 The American Fertility Society classification of endometriosis. (From American Fertility Society. 
Classification of endometriosis 1979)
 (57)
 
 
This classification scheme allows for significant flexibility in point assignment, which 
enables any case to be categorized, including those that were recognized to not follow 
the assignment. This allows any case to be categorized, including those that were 
recognized to not follow the usual chronology of disease progression and for a 
comprehensive pelvic evaluation at the time of staging. It also allows for easy and clear 
communication among practitioners. However, some authors stated that the features of 
infertility were emphasized, but not necessarily related to pelvic pain
(58)
. 
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Fig 2. The American Fertility Society revised classification of endometriosis. (From American Fertility 
Society. Revised classification of endometriosis
(59). 
 16 
 
Hassan  offered a modification that increased the point scoring system when the 
endometriotic lesions extends into the utero-sacral ligaments and the deep 
retroperitoneal space
(58)
 .  In response to the criticism, the AFS revised its classification 
scheme (Fig 2)
(59)
. The Revised American Fertility Society (R-AFS) classification of 
endometriosis was more detailed and formed a separate category for minimal disease 
while eliminating the extensive disease category and a three-dimensional assessment of 
disease was included that differentiated superficial from invasive disease. 
 
The limitations of the R-AFS classification system have been mentioned viz, 
Arbitrariness of the scoring system, its potential for observational error, limited 
reproducibility and failure to encompass lesion morphologic type
(57)
. 
 
 
2.4 Extrapelvic Endometriosis 
 
Extrapelvic endometriosis is defined as endometriotic implants found elsewhere in the 
body, including the gastrointestinal tract, urinary tract, pulmonary system, extremities, skin, 
and central nervous system
(60)
. It‟s true prevalence is unknown because of a lack of 
epidemiologically well-defined studies. Case reports scattered throughout the surgical and 
gynecologic literature include findings of extrapelvic endometriosis in virtually every organ 
system and tissue in the body.  
The diagnosis of extrapelvic endometriosis is more difficult because of the variety of 
symptoms, signs, and different locations, and the low clinical suspicion that doctors and 
general surgeons have for the disease
(61)
. It is generally diagnosed in a slightly older 
population and with less frequency than pelvic endometriosis. Several studies have shown 
that the median age at diagnosis is 34 to 40 years, compared with the commonly reported 
range of 25 to 30 for pelvic endometriosis
(61-63)
. 
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Extrapelvic endometriosis is divided into four classes, as suggested by Markham's 
classification scheme: Class I designates disease of the gastrointestinal tract; class U, 
organs of the urinary tract; class L, disease of the lungs and thorax; and class O refers to 
disease at all other sites
(64)
. Classes are subdivided further based on intrinsic or extrinsic 
disease and on the size of the lesions. This classification system is not in widely 
accepted. 
 
2.5 Endometriosis and Infertility 
The infertility problems which include ovulatory disorders, tubal obstruction and semen 
abnormalities are relatively easy to diagnose and they have been estimated to account 
for infertility in about 75% of affected couples
(65)
. Endometriosis has been said to 
account for infertility in the remaining 25% and is estimated to occur in 40% of women 
of these affected couples
(66)
. However, in a study of 500 cases with recto-vaginal 
nodules, Donnez et al., reported that 64.8% women had associated infertility
(67)
. 
 
There is controversy in the mechanism of infertility in women with endometriosis and 
this likely depends on the stage and grade of the disease. Endometriosis is staged 
surgically using the R-AFS staging system and it ranges from minimal presence of 
ectopic tissue (1-5mm lesions on the pelvic peritoneum) (stage 1) to severe anatomic 
distortion (deep infiltrating endometriosis with major pelvic adhesions and obliteration 
of normal pelvic organ relationships) stage (IV) (see Fig 2) (59). 
The evidence is inconclusive whether the early stage disease (stage I or II) could be the 
cause of infertility, although it may be the only abnormality identified during infertility 
work-up. It is hypothesized that there is overproduction of prostaglandins, 
metalloproteinases, cytokines and chemokines in women with minimal or mild 
endometriosis, leading to inflammatory processes that impair peritoneal, ovarian, tubal 
and endometrial function resulting in defective folliculogenesis, fertilization and 
implantation
(36, 68)
. This theory is supported by studies showing that the numbers of 
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macrophages and cytokines are raised in the peritoneal fluids of women with 
endometriosis  which  can inhibits sperm function and cilliary function in vitro
(69-72)
. 
 
 
2.6 Endometriosis and Pain 
 
Chronic pain is usually defined as pain that continues beyond the expected healing 
time
(73)
. It is a non-cyclic pain localised in the anatomic pelvis, anterior abdominal wall 
at or below the umbilicus, the lumbo-sacral back, or the buttocks. The pain is severe 
enough to cause functional disability for women to seek medical help and this pain lasts 
for six months or beyond
(74)
.  
 
The pain symptoms of endometriosis are: dysmenorrhea, dyspareunia, and chronic 
pelvic pain 
(75)
. The symptoms can be non-cyclic or non-menstrual. In women who had 
laparoscopy for chronic pelvic pain, at least 33% were found to have endometriosis, 
whereas the incidence of endometriosis was found to be only 5% in those who had 
laparoscopy for indications other than for pelvic pain or infertility
(76)
. The association of 
endometriosis with chronic pelvic pain is further supported by the improvement of pain 
observed with surgical treatment of endometriosis, but it is difficult to prove that 
endometriosis causes pelvic pain
(77)
.  
 
Several theories have been hypothesized to explain the pain caused in endometriotic 
tissue, production and release of prostaglandins in relation to pain, inflammatory 
mediators, fibrosis and cyclic haemorrhages from endometriotic tissue in patients with 
RVE. Anaf et al., proposed that pain elicited during physical examination is caused by 
pressure exerted on the nodule and this suggests a close relationship between the lesion 
and the nerve structure in the recto-vaginal septum
(78)
. The majority of patients with 
RVE have chronic pelvic pain. Most experts in gynaecology prefer a duration of six or 
more months as the major criterion to define chronic pelvic pain, but three months is 
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more consistent with the criterion proposed by the International Association for the 
Study of Pain
(79)
. 
 
Pain caused by endometriosis is usually visceral in origin as endometriosis occurs most 
commonly in pelvic viscera and visceral peritoneum. The clinical characteristics of 
visceral pain are: (i) it is not elicited by all viscera; (ii) may always be functional and 
(iii) it is not always injury related. It often results in somatic referral pain, possibly 
because of central convergence of visceral and somatic afferents; and it tends to be 
poorly localized, probably because the nociceptive afferents within the viscera are of 
the low concentration
(80)
. The pain is generated in response to:  distension of a viscous 
or an organ capsule, spasm of visceral muscular fibres, ischemia from vascular 
disturbances, haemorrhage, neoplasm, inflammation, or to traction on mesentery. All of 
these characteristics of visceral pain are important in trying to understand the 
complexity of endometriosis associated pelvic pain. Inflammation has a particularly 
important role in visceral endometriosis associated pain
(81)
. 
 
There is evidence that endometriosis can cause nociceptive pain (transduction, 
transmission, modulation, and perception). Firstly, for endometriosis to cause pain via a 
nociceptive mechanism there should be nociceptor near endometriotic lesions so that 
endometriosis can act as a noxious stimulus and trigger transduction. There is ample 
evidence for the presence of nociceptors in or near endometriotic lesions. Tokushige et 
al (2006), showed that the concentration of nerve fibres in peritoneal endometriotic 
lesions of women with symptoms was 6-fold greater than in peritoneum of disease free 
women. Most of the nerve fibres in close proximity to endometriosis glands were 
shown to be unmyelinated nerve fibres. In addition, several patients with endometriosis 
also had endosalpingiosis lesions, and interestingly the concentration of nerve fibres in 
endosalpingiosis lesions was not different from that in normal peritoneum
(82)
. 
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It is known that endometriosis may cause somatic nociceptive pain as well. Anaf et al., 
demonstrated that in the recto-vaginal endometriosis nodules, the myelinated nerve 
fibres (likely to be Adfibres) were present and were usually encapsulated in nodular 
fibrosis. They reported that there was perineural and endoneural invasion, and 
demonstrated that pain levels correlated with the amount of nerve encapsulation in 
fibrosis and endometriotic lesions, and the degree of perineural and endoneural 
invasion. Ad fibres generally transmit first pain and somatic pain and their presence in 
recto-vaginal endometriosis nodules may explain the marked tenderness that is 
observed with palpation of these deeply invasive lesions
(78)
. 
 
 
2.7 Clinical Manifestation and Diagnosis of Recto-vaginal Endometriosis 
 
Women with RVE may present with the classical symptoms of endometriosis which 
may be variable and unpredictable. In general, the following symptoms occur in 
patients with endometriosis: severe dysmenorrhea, deep dyspareunia, chronic pelvic 
pain and ovulation pain. Symptoms associated with bowel or bladder dysfunction, with 
or without abnormal bleeding or pain, infertility, chronic fatigue and dyschezia are also 
mentioned
(83)
. 
 
Almost all patients with RVE present with symptoms of dyspareunia, dyschezia, rectal 
bleeding, diarrhoea, tenesmus and bowel obstruction
(3)
. When rectal infiltration occurs, 
dyschezia and rectal bleeding can occur and usually coincides with menstrual 
bleeding
(84)
. Dyspareunia typically is localized to the posterior vaginal wall and occurs 
during deep vaginal thrusting. Two recent studies have found that severe dyspareunia 
and painful defecation during menstruation is predictive of DIE and RVE
(85)
. Apareunia 
and abdominal bloating are other symptoms that are not infrequently reported
(86)
. 
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There is evidence suggesting that many patients with recto-vaginal endometriosis seek 
help late after significant unnecessary suffering has occurred
(3)
. The gastro-intestinal 
symptoms of patients with RVE are similar to those of irritable bowel syndrome (IBS) 
and these patients are often mismanaged
(87)
. It is not uncommon for women seen by a 
gynaecologist not to spontaneously disclose gastro-intestinal symptoms. This is 
probably due to the fear of embarrassment, or they do not associate their symptoms to 
gynaecological pathology. 
 
 
Diagnosis of Recto-vaginal Endometriosis 
 
The presence of RVE is typically suggested by physical examination; finding of a 
painful recto-vaginal nodule or findings on pelvic imaging or during laparoscopy 
performed to evaluate pelvic pain or infertility. Pre-operative diagnosis of RVE is of 
paramount importance for the establishment of the precise distribution and extent of 
invasion of the lesions and this helps the surgeon decide on the best management option 
of these patients.  
 
The clinical history, vaginal and/or rectal examination as well as imaging play a crucial 
role in the management plan of women with endometriosis. Clinical examination 
findings of a fixed retroverted uterus, a palpable or visible nodule in the posterior fornix 
and tender irregular uterosacral ligaments are highly diagnostic of RVE. When the 
clinical examination is performed at the time of menstruation, the sensitivity to 
diagnose RVE  is increased
(88)
. 
 
CA 125 is expressed by both eutopic and ectopic endometrium. In women with 
advanced endometriosis, the plasma concentrations are raised towards the end of luteal 
phase and during menstruation compared to women without the disease. Sensitivity of 
36% and specificity of 87% has been reported in diagnosing deeply infiltrating 
endometriosis
(89)
. This blood marker is nonspecific and is also elevated in women with 
ovarian malignancy and other inflammatory disease processes of the pelvis. However, 
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when compared with laparoscopy, measuring serum CA125 levels for endometriosis is 
of no value as a diagnostic tool. Mol et al, found that the sensitivity of CA 125 was only 
28% with a specificity of 90% (corresponding likelihood ratio of a raised level is 2.8) 
for diagnosing all disease stages of endometriosis. However, for moderate to severe 
endometriosis, it was found to perform better with a specificity of 89% and sensitivity 
of 47% (corresponding likely-hood ratio of a raised level is 4.3) for diagnosing the 
disease
(90)
.  
 
Diagnostic imaging for evaluation of recto-vaginal endometriosis include: transvaginal 
and transrectal sonography, magnetic resonance imaging (MRI), Intravenous 
Urography (IVU) and double-contrast barium enema.  
 
 
Transvaginal Sonography 
 
Transvaginal sonography is the first-line imaging tool when RVE is suspected
(91)
. The 
radiologist should be informed when suspecting RVE so that the sigmoid colon may be 
evaluated during imaging. Numerous studies suggested that transvaginal sonography 
plays a vital role in the diagnosis of RVE, especially if the nodule involves the recto-
sigmoid colon with a sensitivity of between 74% and 98% and specificity of between 
88% and 100%
(92-94)
. 
 
The limitations of transvaginal ultrasound to diagnose RVE include
(91)
: 
1. Imaging field extends only to the rectosigmoid junction 
2. It cannot assess the depth of infiltration into the vaginal or rectal walls 
3. It cannot determine the distance of the nodule from the anal junction which 
helps to determine the extent of surgical resection. 
 
Sonovaginography has been reported to increase the sensitivity of transvaginal 
ultrasound. In this procedure, the transvaginal probe is introduced into the vagina after a 
saline solution has been infused. One study evaluated 46 women scheduled for the 
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resection of the clinically suspected recto-vaginal wall lesion. Sonovaginograhy 
diagnosed 91% of the pathologically confirmed endometriotic lesions compared to 44% 
with the conventional transvaginal sonography alone. Specificity was found to be 86% 
and 50% respectively
(95)
. 
 
Rectal Endoscopic Ultrasound 
 
It is not typically used as the first-line study tool for evaluating RVE. It has been found 
by numerous studies, although relatively small, to be a useful clinical tool in the 
diagnosis of RVE. Its sensitivity and specificity to diagnose RVE infiltrating the rectal 
wall is reported to be 97% and 96%, respectively
(96)
. Studies comparing transrectal 
sonography and MRI have found that transrectal sonography is superior to MRI for 
detection of rectal wall invasion. Rectal endoscopic sonography has been advocated for 
the diagnoses of endometriosis involving the rectal wall, recto-vaginal septum, 
uterosacral ligaments or recto-sigmoid colon
(96, 97)
.  
 
Magnetic Resonance Imaging (MRI) 
 
MRI has only been shown to have high sensitivity, specificity, positive and negative 
predictive values as well as accuracy in evaluating the extent of the lesion
(98)
. It has 
been found to be better than transvaginal sonography for the diagnosis of 
endometriomas and small peritoneal lesions. It sensitivity is reported to be 70% for the 
disease confirmed by histology
(92)
. However, it was not found to be superior to 
transvaginal or rectal endoscopic ultrasound for evaluating endometriosis of the rectal 
wall
(97, 99)
. These findings were also demonstrated in a retrospective study of 92 women 
that compared the three modalities and found similar sensitivities, MRI: 87 %; 
transvaginal ultrasound: 94%; and rectal endoscopic ultrasound; 89%; and the 
specificities were 93, 100 and 93% respectively. Surgical exploration was used as the 
reference standard in these studies
(100, 101)
. However, MRI can be used for women in 
whom a rectovaginal disease is suspected but is not found after evaluation with both 
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physical examination and transvaginal ultrasound. Its limitations are that fibrosis of the 
endometriotic tissue can change the signal intensity pattern and also, the bowel 
peristalsis can cause motion artefacts in the image
(91)
. 
 
Computerized Tomography 
 
Computerized Tomography (CT scan) was reported to have a good sensitivity and 
specificity for diagnosing bowel endometriosis (99% and 100% respectively).  This was 
reported in a study of 98 women where computerized tomography was used in 
combination with colon distension using water enteroclysis to determine the presence 
and depth of bowel endometriotic infiltration
(102)
.  
 
Double Contrast Barium Enema 
 
Its use in the evaluation of RVE is mainly when gastrointestinal symptoms suggesting 
partial bowel obstruction are present. In a retrospective study of 108 women with 
symptoms suggestive of intestinal endometriosis, Double Contrast Barium Enema 
showed an accuracy of 99% for predicting the need of intestinal surgery
(103)
. A recent 
study showed its sensitivity to be 88% and specificity of 93% for bowel endometriosis 
in 234 women studied and it was found to be superior to MRI for detecting bowel 
invasion
(104, 105)
. 
 
Diagnostic Laparoscopy 
 
For a definitive diagnosis of RVE, visual inspection of the pelvis with laparoscopy is 
regarded as the gold standard investigation tool, unless the disease can be visualized in 
the posterior vaginal fornix. However, the disease may not be readily visualised at 
laparoscopy since it is often occluded by the posterior cul-de-sac adhesions. RVE does 
not often appear as the classical discolouration of pigmented lesions at laparoscopy; it 
commonly appears as a superficial scar tissue in the cul de sac and can be easily missed. 
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However, with indirect palpation of the scar tissue using a laparoscopic probe, this 
initial superficial scarring tissue can be eventually be much deeper
(106)
. 
 
 
2.8 Management of Recto-vaginal Endometriosis 
 
The management of endometriosis can be achieved in three ways: surgery; medical or 
both. Surgical excision is the effective method and is regarded the gold standard in the 
management of recto-vaginal endometriosis
(107, 108)
. RVE remains a significant cause of 
morbidity, and often present with a variety of symptoms that can sometimes be severe. 
Its management is guided by several factors, including the indication for treatment, 
anatomic location of the disease and patient preference. Women with asymptomatic or 
mild symptoms that are not bothersome can be managed expectantly. However, RVE 
containing adenomyotic nodules is best managed by surgery because medical treatment 
is relatively ineffective in these type of women
(109)
. 
 
2.8.1 Expectant management 
 
When pain symptoms are minimal or are effectively managed by long-term medical 
treatment, then expectant management of RVE is a reasonable option. In a case series 
by Fedel at al., 88 women were managed for RVE, two women required surgery 
because of increasing pain severance and four asymptomatic women required surgical 
intervention because of increasing size of nodules as noted by ultrasound. Only 24 of 
these women used oral contraceptives while the others did not receive treatment. The 
study had a mean follow-up of 68 months
(10)
. 
 
2.8.2 Medical management 
 
RVE remains a significant cause of morbidity. Medical treatment avoids the risks 
associated with surgery. This is significant since extensive pelvic dissection or bowel 
resection may result in complications such as genital tract fistulae, bladder injury or 
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dysfunction or bowel anastomotic leakage.  Medical therapy is relatively ineffective for 
treatment of women with RVE and surgery as first line of treatment is advocated for 
women with RVE containing adenomyotic nodules
(109)
. Vercellin et al., also supported 
surgical intervention as the first-line option for women with severe RVE
(110)
 . Also, 
Varcellini et al., noted that women with endometriosis undergo several surgeries and 
the risk of surgical complications increases with repeat procedures due to multiple 
exposures to surgical risk and development of scar tissue
(111)
. 
 
There are no studies that have compared medical with surgical treatment for RVE. 
Donazol and GRHa appear to benefit the affected women in terms of disease regression 
but may not be recommended for long-term use because of their side effects
(2)
. 
However, extensive counselling, optimal analgesia, progestogens or the combined oral 
contraceptives are accepted for empirical treatment of pain presumed to be caused by 
RVE when definitive diagnosis is not yet confirmed. Literature is unclear as to the best 
regimen of combined oral contraceptives suitable for endometriosis, viz., conventional, 
continuous or a tricycle regimen. GnRHa may be used but the drug is expensive and is 
associated with more side effects and there are concerns about its negative effect on 
bone mineral density. However, there is an increased risk of disease recurrence 
following cessation of medical treatment as the available medical therapies for 
symptomatic disease generally inhibit ovulation and this form of treatment is reserved 
for women with no short-term fertility interests
(112). Suppression of ovarian function by 
hormonal treatment for a minimum period of six months lowers the occurrence of pain 
associated with endometriosis. Some of the drugs studied were: Combined oral 
contraceptives, Danazol, Gestrinone, Medroxyprogesterone acetate, and GRHa
 
and it 
was shown that hormonal therapy is equally effective but the side-effects and cost 
profiles differ
(50, 113)
.  
 
Non-steroidal anti-inflammatory drugs (NSAIDs) appear to be reasonable for the 
treatment of endometriosis as the disease results in chronic inflammation. Although 
these drugs have been used often as the first line therapy for pain induced by 
endometriosis, their analgesic effect for the disease has not been studied fully.  
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Kauppila et al., found that this group of drugs is effective in reducing the pain 
associated with endometriosis, however, gastrointestinal side effects were more 
common with Aspirin and Indomethacin and also there were psychic complaints in 
women treated with Indomethacin as compared to Aspirin or placebo
(114)
. There is no 
evidence to demonstrate whether NSAIDs (specifically naproxen) are effective in 
managing pain caused by endometriosis. Furthermore, there is no evidence to show 
whether any individual drug is superior to another
(115)
. In a review of the topic of 
medical treatment of endometriosis, Vercellini et al., concluded that despite problems in 
interpretation of data, medical treatment in terms of pain relief appears to be effective in 
women with RVE
(111)
. 
 
2.8.3 Surgical management 
 
Surgery is advocated as the first-line treatment option for women with severe RVE
(112)
. 
The parameters of consideration include the size of the nodule and the extent of 
affected bowel circumference, the depth of invasion into the rectal wall, other 
endometriotic foci in the pelvis, experience and skills of the surgeon
(116, 117)
. The most 
common surgical procedures employed in the management of RVE are shaving 
(superficial thickness excision), resection of the nodule together with the anterior side 
of the rectum (full thickness discoid resection) and colon or rectal segmental 
resection
(118)
.  
 
This form of surgical approach may be conservative or radical. Conservative surgical 
treatment consists of excising the symptomatic endometriotic lesions and leaving the 
surrounding structures intact while radical treatment encompasses segmental bowel 
resection, hysterectomy and bilateral salpingo-oophorectomy with removal of 
symptomatic lesions at other sites. The surgical approach is usually by laparoscopy but 
may also be by laparotomy depending on the anatomic site of the disease, complexity of 
the procedure and the surgeon‟s laparoscopic skills.  
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Laparoscopic surgery for RVE is often difficult, requires skills acquired by intensive 
training and is reserved for women with severe disabling symptoms not responding to 
medical therapy and in  women who have endometrioma or urinary or bowel 
obstruction. Laparoscopy offers better visualization of endometrial lesions compared to 
laparotomy and is therefore the surgical treatment of choice.  It involves various energy 
sources for the excision of deep nodules. Complications with laparoscopic surgery are 
not infrequent. However, serious complications that may be encountered during surgery 
range from uncontrolled bleeding, injury to the bowel and urological system (bladder 
and ureter), conversion to laparotomy and gas embolization. Post-operative 
complications include pyrexia, bowel leaks, urine leaks, voiding and bowel 
dysfunctions, urinary tract infections and wound infection
(119)
.  
 
Conventional surgery utilizes electrosurgical energy which is associated with the 
hazards of bowel injury when operating in close proximity to the rectum. When the 
disease involves the bowel, the risk of severe complications during surgery is increased 
and a multidisciplinary approach in management of the disease is advisable. The choice 
of surgery will depend on the surgical skills available and to the future reproductive 
plans of the women
(9)
. 
 
Numerous surgical approaches have been proposed for RVE when the rectum is 
involved but no consensus has been reached as to which form of therapy is best when 
the muscular rectal layer is involved
(88)
. Ford et al., in their cohort study of 60 women, 
reviewed the quality of life after surgical resection of RVE.  In twelve women, excision 
was performed by laparotomy and in forty-eight by laparoscopy. Improvement in 
quality of life was reported by 86% and 61% had a good response. They also found that 
the response  was good and the quality of life issues was significantly improved  in 
those women who had segmental resection of the rectum, or those who had 
simultaneous hysterectomy, in addition to treatment for endometriosis
(11)
.  
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2.8.3.1 Conservative Surgery 
 
Conservative surgery for RVE involves dissection of the recto-vaginal space and 
removal of the endometrioatic nodule(s) as well as laparoscopic ablation of 
endometriotic implants with cauterization or laser. The authors who advocate for 
conservative treatment of RVE argue that it achieves decreased rates of complications 
and higher pregnancy rates with similar rates of symptomatic improvement thereby 
preserving fertility when compared with intestinal resection
(118)
. To date, comparative 
efficacies of the ablative methods have not been evaluated through randomized 
controlled trials.   
 
The common procedures employed in the conservative treatment of RVE are those 
aiming for simple resection of the lesion after separating the endometriotic nodule from 
the rectal wall, layer-to-layer excision (shaving) of the lesion with no resection of the 
entire thickness of the intestinal wall
(118, 120)
. Local excision of the nodule (shaving and 
discoid resection) is employed when there are no signs of rectal wall invasion found on 
pre-operative workup. It carries fewer complications and good clinical results can be 
expected. However, in patients with bowel invasion, systematic shaving is the least 
aggressive approach and it carries a low rate of complications
(118)
. Donez et al., using 
this technique, noted 3.2% serious complications, 8% relapse, and 84% pregnancies 
occurred after the surgical intervention with 57% pregnancies occurring spontaneously. 
There were no alterations in bladder function or intestine function one month after the 
shaving intervention technique
(67)
.  
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2.8.3.2 Radical Surgery 
 
Radical surgery for RVE which encompasses hysterectomy or complete excision of all 
endometriotic tissue including segmental bowel resection if needed, seems to result in 
significant post-operative pain relief
(11, 119)
. Currently, some gynecological surgeons 
advocate for colorectal resection in symptomatic women with severe RVE, as this 
offers the best treatment for improvement of pain and relapses are avoided if 
concomitant resection of all intestinal endometriotic foci is done
(121, 122)
.  Other groups 
prefer endometriotic nodule excision rather than colon or rectal resection since the 
former  has shown a reduced rate of morbidity and the pain recurrence post-surgery is 
similar between the two approaches
(60, 120)
. The first case reports on the feasibility and 
safety of complete laparoscopic segmental bowel resection of RVE involving the 
sigmoid was undertaken in the USA, back in 1992 by Nezhat et al. In their study of 16 
women with RVE, there were no major intra-operative or post- operative complications 
reported and the procedure was well tolerated
(108)
.  
 
Donnez et al., in a study addressing surgical resection of RVE, reported an incidence of 
0.8% rectal perforation, 0.4% of delayed haemorrhage (<24 hours post- surgery) and 0, 
8% of urinary retention. The perforation was detected during the procedure and the 
defect was repaired either by colpotomy(n = 2) or by mini laparotomy (n = 2)
(119)
. 
Slack et al., using laser excision for RVE, identified rectal wall defect in 25% of 
women that required repair. Fourteen percent required full thickness repair and 11% 
had a partial defect repair of the rectus muscularis. One woman had to undergo 
resection of a recto-sigmoid colon segment because the disease had invaded the full-
thickness of the colon and this was associated with diverticulitis. Two other women had 
segmental recto-sigmoid resection because of circumferential lesion.  
 
Minor post-operative complications were observed in 3.2%, of which post-operative 
urinary retention occurred in all patients. This was alluded to trauma of the 
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parasympathetic plexus with subsequent temporary denervation of the bladder. This 
complication was managed with urinary catheterisation for a maximum of 7 days. There 
were 3% major complications. Two developed recto-vaginal fistulae, which presented 
on days 5 and 7 post-surgery and required exploratory laparotomy with creation of a 
temporary diverting loop colostomy. One patient developed both recto-vaginal and 
uretero-vaginal fistula. A temporary colostomy was also created and ureteric re-
implantation done. Ureteric stenting was performed in one woman. The average 
duration of hospital stay was 3.4 days, ranging from one to eleven days)
 (9)
. 
 
Ford et al., studied pain, quality of life and complications following radical resection of 
RVE. They found that women who had a hysterectomy or a disc or segmental resection 
of the rectum showed good response and had a normal quality of life  after the surgical 
intervention and concluded that hysterectomy and rectal resection resulted in a good 
response and better quality of life
(11)
. 
 
The risk of recurrence of endometriosis is high in younger patients.  In a study by Fedel 
et al., the recurrence of pain symptoms viz. dysmenorrhea, pelvic pain, or dyspareunia 
occurred in 21 patients, with a cumulative recurrence rate of 28% at thirty six months. 
Dysmenorrhea recurred in 21(25.3%) patients; pelvic pain recurred in 16 (19.3%) 
patients, and dyspareunia recurred in 21(25.3%) patients. The evidence of DIE 
recurrence was detected in 25 patients. This was detected on clinical examination or on 
transrectal sonography and this was found to be equivalent to a cumulative recurrence 
rate of 34.2% at thirty-six months. There was a need for surgical intervention and 
medical treatment in 21 women because of DIE recurrence (thirty six month cumulative 
rate was 27%)
(10)
. The recurrence rate of endometriosis after laparoscopic ablation is 
about 40% in 10 years
(123)
. 
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2.8.3.4 Energy Sources 
 
Laparoscopy uses different sources of energy including monopolar electrosurgery, 
bipolar electrosurgery, argon beam coagulation, laser, ultrasonic energy and pulsed 
bipor technology. Electrosurgery is the commonest energy source utilized. 
 
Electro surgery defined as the cutting and coagulation of tissue using high-frequency 
electrical current
(124)
.  Electrosurgical units (ESU) used the in the operation room 
convert the standard electrical frequencies from the wall outlet (50-60Hz) to much 
higher frequencies, 500,000 to 3000,000 Hz
(124)
. The tissue effect can be achieved by 
cutting or coagulation. In the cutting mode, the ESU generates a continuous (or 
undulated), low-voltage current, concentrating the energy on a small area (high current 
density) whereas, in the coagulation mode, the ESU generates an interrupted 
(modulated), high-voltage current, dispersed over a large surface area (low current 
density). 
 
Monopolar Electrosurgery 
 
In this energy source, the electrical current created in the Electrosurgical units (ESU) 
passes through a single electrode to the tissue, causing the desired tissue effect and the 
effect occurs almost near the electrode. The current passes through the patient to 
complete the circuit. Either cutting or coagulation mode may be used to achieve the 
desired tissue effect but the cutting mode is preferred when thermal spread is 
undesirable such as near the ureters, bowel or other  vital structures, whereas, 
coagulation is preferred in high resistant areas,  such as, fatty tissue  and scar tissue. In 
laparoscopic surgery, conventional monopolar electrosurgery scissors have several 
shortcomings, including the risk of thermal injury to the viscera, difficulty in achieving  
haemostasis and smoke production, necessitating  additional tools such as bipolar 
graspers, sutures and clips to be used
(124)
. 
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Bipolar Electrosurgery 
 
In this energy source, the electrical current created in the ESU is confined to the tissue 
between the electrodes of the surgical instrument. It is generally performed at low 
voltage (cutting mode) since tissue impedance is relatively low due to the proximity of 
the two electrodes. Compared to Unipolar electro surgery, the damage to tissue with 
Bipolar electrosurgery is less resulting in reduced depth of penetration and therefore 
less risk of tissue perforation
(125)
. This device  has less smoke production and has better 
haemostatic capability than Monopolar
(126)
. Since there is no current return to the 
patient, this reduces ground pad and alternate site burns and capacitive coupling. 
 
 
The Ligasure System 
 
The Ligasure System uses a new bipolar technology for vascular sealing with a higher 
current and lower voltage (180 V) than conventional electrosurgery. The system 
combines pressure and energy to create vessel fusion in a unique manner leading to 
melting of the collagen and elastin proteins in the vessel walls, changing them to a 
permanent, plastic-like seal. It does not depend on a proximal thrombus when compared 
with the classic bipolar electrocautery. When the seal cycle is complete, an inbuilt 
feedback-controlled response system automatically discontinues energy delivery, 
reducing guesswork and the thermal spread is minimized to approximately 2 mm for 
most LigaSure instruments. There is no sticking or charring and the seals can withstand 
three times normal systolic blood pressure
(127)
. 
 
Laser 
 
The Light Amplification and Stimulated Emission of radiation is sometimes used as an 
alternative to electrosurgery but the popularity in gynaecological surgery has 
declined
(128)
. However, it is still useful in some gynaecological operations such as 
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cervical conization, laparoscopic excision of endometriosis and treatment of vulval 
intraepithelial neoplasia
(129, 130)
. It consists of an energy source, a gating/focusing 
mechanism and radiating medium. The type of medium includes carbon dioxide or 
potassium-titanium-phosphate medium that determine the wavelength emitted
(129)
. 
 
Harmonic scalpel 
 
The Harmonic scalpel is an ultrasonic cutting and coagulation device that converts 
ultrasonic energy into mechanical energy at the functional end of the instrument. It is 
designed to coagulate and cut tissues. It uses a high energy ultrasound that is beyond 
the range of human hearing (20 000) cycles per second. It is powered by a generator 
and houses an acoustic transducer that converts electrical energy into high frequency 
mechanical vibrations. It allows excellent cutting and facilitates dissection. It works at 
a relatively low temperature, thus reducing thermal injury and allows rapid tissue 
healing. This instrument has no electrical current passing through the patient, so there 
is no danger of electrical damage to the nearby tissues
(131)
. The Harmonic scalpel has 
been used successfully in numerous open and laparoscopic procedures
(132, 133)
. Its 
advantages include minimal thermal spread and decreased tissue charring and smoke 
formation when compared with the traditional electrosurgical instruments. There is no 
risk of electrical injury due to the absence of the electrical current within the 
patient
(134)
. Its disadvantages include: limited ability to coagulate vessels larger than 
3-5mm, increased cost of disposable instruments, potential for extensive thermal 
spread at high energy levels (level 5) for more than five seconds and user- dependant 
nature of the instrument
(135, 136)
. 
Harmonic scalpel has been used as an energy source in RVE and its popularity is 
increasing because of the benefit it provides. This is ultrasonic energy and avoids the 
problems associated with electrosurgical energy, namely thermal injuries, direct and 
capacitated coupling and electrical pad injuries. The surgical effect is dependent on 
the power setting, the grip pressure, the contour and shape of the applied blade and 
the tension applied to the tissue. It also appears that the „shear‟ handle and tip is the 
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most common instrument utilized with the Harmonic energy source. The shear allows 
for fine dissection, coagulation, cutting and could be used as a retractor during 
surgery. According to our knowledge, the usage of the Harmonic scalpel in the 
management of RVE addressing outcomes and complications has not been evaluated.  
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Chapter 3: Study 
3.1 Aims 
 
The main aim of this study was to evaluate operative and post-operative complications 
and outcomes of laparoscopic surgery using the Harmonic scalpel in patients with RVE. 
Furthermore, referral patterns and pre-operative work up were evaluated. 
 
3.2 Methodology and Statistics 
 
The study was a retrospective chart review analysis of all women who underwent 
laparoscopic surgery for recto-vaginal endometriosis using the Harmonic scalpel 
between January 2004 to December 2010 at the gynaecological endoscopic unit at 
Inkosi Albert Luthuli Central Hospital(IALCH). Cases with non-infiltrating 
endometriosis and those with ovarian and peritoneal nodules were excluded except for 
those with nodules in the recto-vaginal septum. 
 
Eligible women were identified from clinical database (all clinical records in this 
hospital are computerized and kept in a database (MEDICOM, India)and were analyzed 
with respect to age, parity, referral pattern, presenting complaints, operative 
complications and followed up to a minimum of 3 months after surgery (Appendages 
3.6.4). The study cohort was limited to women with RVE confirmed by histology.  
 
Patients with suspected recto-vaginal endometriosis were referred to the endoscopic 
unit at IALCH from regional hospitals in the Durban metropolitan area. A detailed 
history including symptoms viz. chronic pelvic pain, dysmenorrhea, dyspareunia and 
defecatory symptoms were evaluated. 
 
 
This was followed by a detailed clinical examination which included weight, height 
(BMI), abdominal palpation and a pelvic examination which included evaluation of 
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uterus, position of the cervix, assessment of the recto-vagal space and uterosacral 
ligaments to establish the thickness of the nodule.    
 
Pre-operative workup included blood investigations viz. full blood count, urea and 
electrolytes as well as CA 125 levels. Imaging evaluation included both pelvic and 
trans-abdominal ultrasound and in selected cases, CT scan pelvis, MRI, Barium enema 
and Intravenous urography.  Patients had a Barium enema if rectal wall infiltration was 
suspected on clinical history and examination. Patients were counselled with regard to 
the surgery to be done, likely complications and possible risks of conversion to 
laparotomy. In addition, risks to rectal injury and the potential need for a colostomy and 
the risk of haemorrhage with subsequent blood transfusion were discussed. Informed 
written consent was subsequently taken.  
 
All surgical procedures were preceded by full bowel preparation of three days and 
included a liquid diet. The surgical technique involved the insertion of a Verre‟s needle 
for the insufflation of gas into the peritoneal cavity. The primary 5-mm port was placed 
in the umbilicus. If there was history of previous abdominal surgery, the Palmers point 
was used as the entry site. Laparoscopic surgery was performed using standard 4 
puncture port entry.Three secondary ports, of which two 5-mm each, were placed under 
direct vision into the lower pelvis bilaterally, 2cm above the mid-point between lateral 
umbilical ligament and anterior superior iliac spine. A third port, namely, an 11mm port 
was placed midway between the symphysis pubis and umbilicus.  
 
On peritoneal entry, the entire pelvis and abdominal cavity was inspected. This was 
followed by freeing of any adhesions, mobilization of the ureters, dissection of both 
para-rectal spaces and separation of the rectum from the vagina. Any nodules attached 
to the vagina were resected. The shaving technique was favored over segmental 
resection of the bowel in patients with RVE. 
 
Defects in the rectum following excision of the lesions were repaired laparoscopically 
in 2 layers when feasible using polyglycolic sutures. If there were technical difficulties, 
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then conversion to laparotomy was undertaken. All nodules were removed from the 
cavity via a 11mm port or via colpotomy (incision in the vagina through the posterior 
fornix). Concurrent endometroitic lesions at other sites (uterosacrals, ovarian, 
peritoneal) were also resected using the harmonic scalpel. All endometriotic tissues 
were sent for histological confirmation. Both intra-operative and post-operative 
complications were documented.  
 
At the end of the surgical procedure, bipolar cautery was used to achieve optimal 
haemostasis and an underwater air leak test was done to check for the integrity of the 
bowel. This involved insertion of Foley catheter into the rectum and insufflation of gas 
using a Toumy syringe. If findings were equivocal then the patient was kept nil per 
mouth and a gastrograffin test was done the following day to rule out any leakage. 
 
The main energy source utilized during operation was the Harmonic scalpel. The 
Harmonic scalpel is designed to cut and coagulate tissues. It uses an ultrasound at 
frequency of 55500 cycles per second. It is powered by a generator and houses an 
acoustic transducer that converts electrical energy into high frequency mechanical 
vibrations. It allows for excellent cutting and facilitates dissection. It works at a 
relatively low temperature, thus reducing thermal injury and allows rapid tissue healing. 
This instrument has no electrical current passing through the patient, so there is no 
danger of electrical damage to the nearby tissues
(131)
. 
 
The post-operative surveillance included monitoring of the temperature, blood pressure 
and pulse rate. Patients were asked about their general well-beings, pain especially 
abdominal pain and return of bowel activity and they were discharged on day 4 
(Mondays) post-surgery largely because operations are done on Thursdays in our unit 
and it is not practical to discharge patients on weekends. 
 
Major complications were defined as those that carry morbidity that required further 
surgery and those causing delay in discharge from hospital. 
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Patients were followed in the endoscopy clinic once every month for the duration of 
three months post-surgery and were asked to compare and grade the intensity of pain 
both before and after surgery. The need for adjuvant medical therapy was evaluated and 
was prescribed to patients who showed no improvement of pain. Outcomes concerning 
pain and quality of life after surgical intervention or after addition of adjuvant medical 
therapy were informally assessed. Response to treatment was assessed by changes in 
pain intensity. 
 
Statistics 
 
The information was recorded into a structured data sheet and was analyzed using the 
computer program, SPSS (Statistical Package for the Social Sciences) version 15. 
Descriptive variables and frequencies variables were used to analyze data. 
 
Primary outcome in this study included referral patterns, pre-operative investigations, 
operative findings and complications. Secondary outcomes were assessment of pain and 
use of adjunctive medical therapy. 
 
The protocol for the study was approved by the UKZN Post Graduate and Biomedical 
Research Ethics Committee (Appendices A and B). Hospital permission was granted by 
IALCH management for accessing the institution‟s computerized database files 
(Appendix C). 
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3.3 Results 
 
Between January 2004 and December 2010, a total of 105 women underwent 
laparoscopic surgery for advanced stage endometriosis in the gynaecological 
endoscopic unit at IALCH. Thirty-three (31.4%) of the patients had RVE confirmed by 
histology as shown in table 3. The mean age of our study cohort was 35 years the mean 
body mass index (BMI) was 27 (Table 1). The majority of the women were nulliparous 
(42.4%) and the most prevalent racial group were Indians (Fig 3). The majority of 
patients were referred from regional hospitals (51.5%) as shown in Fig 4. 
 
 
 
Table 1. Demographics 
 N Minimum Maximum Mean 
Age (years) 
Weight (kg) 
Height(cm) 
BMI(kg/cm
2)
 
33 
33 
33 
33 
21 
46 
150 
18 
48 
82 
165 
34 
35.36 
67.42 
157.3 
27.15 
BMI = body mass index; kg = kilogram; cm = centimetre   
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Table 2. Patient characteristics 
 Frequency Percentage (%) 
 
Parity                       0 
                                1 
                                2 
                                3 
Racial group             Indian 
                                 African 
                                 White 
 
14 
9 
6 
4 
30 
2 
1 
 
42.4 
28.1 
18.8 
12.5 
90.9 
6.1 
3.0 
 
 
 
 
Fig 3. Racial groups (%) 
 
 
 
90.9 
6.1 3.1 
0 
Indian
African
White
 42 
 
 
Fig 4 Referral pattern (Hospitals)  
 
In twenty four patients, the diagnosis of RVE was already suspected on clinical 
examination or laparoscopy prior referral to IALCH. In addition, some patients had 
pelvic ultrasound, and or CT scan of the pelvis before referral as shown in table 3. 
 
Table 3. Diagnosis of RVE before referral to IALCH 
 
 Frequency (n) Percentage (%) 
Not made 9 27.3 
Clinical  24 66.7 
Laparoscopic  5 15.2 
Sonar 3 9.1 
Ct Pelvis 1 3.0 
MRI 0 0 
 
 
 
0%
20%
40%
60%
Regional Private District
51.5% 
36.4% 
12.1% 
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The most common presenting symptom was chronic pelvic pain which was non-cyclical 
and occurred in all women. Secondary dysmenorrhoea was the second most common 
symptom and was seen in thirty-one patients (93.9%) and painful defecation was seen 
in (36.4%), as shown in table 4. The majority of patients had symptoms for over a year 
(54.5%) and twenty-four patients (72.7%) had symptoms for less than a year before 
visiting a health care professional (Fig 4). 
 
Table 4. Presenting complaints 
Presenting Complaint Frequency (n) Percentage (%) 
Chronic pelvic pain (non-cyclic) 33 100% 
Secondary dysmenorrhea 31 93.9 
Dyspareunia 
                      Superficial 
                      Deep 
19 
7 
12 
57.6 
36.8 
63.2 
Defacatory Symptoms 
Dyschezia 
                    Painful defecation 
                    Rectal bleeding 
                    Irritable bowel 
17 
 
12 
0 
5 
51.5 
 
36.4 
0 
15.2 
 
 
 
Fig 4. Interval between symptoms and 1
st
 visit to health professional 
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Seventeen patients (51.5%) were seen for the first time by health care professionals at 
hospitals and fifteen patients (45.5%) by private general practitioners. The average 
period from the first visit to a health care professional to clinical diagnosis of recto-
vaginal endometriosis was 30.15 months ( 9 to 65) months. The mean duration between 
first visit to IALCH to surgical intervention was 81.61 days. Table 5  
 
Table 5. Interval between symptoms and 1
st
 visit to health professional 
 
 Minimum Maximum Mean 
Duration from 1st visit to HP to clinical Dx of RVE(months) 9 65 30.15 
Duration from 1st visit to IALCH to initial Surgery (days) 14 189 81.61  
 
 
 
 
Twelve patients (36.4%) had problem of infertility and the average period of infertility 
was 10 years ranging from 1- 20years (Fig 5). Thirteen patients had previous surgery, 
namely ten (30.3%) had laparoscopy and three (9.1%) had a laparotomy.  
 
 
 
 
 
 
 
 
 
 
 
Fig 5. Prevalence of infertility 
36.4% 
63.6% 
Yes
No
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Nine patients (27.3%) had mild abdominal tenderness (pelvic) and seven (21.2%) had a 
pelvic mass palpable. The uterus was enlarged in one (3%) and an adnexal mass was 
palpable in five (15.2%). In two patients (6.1%), a lesion could be seen in the posterior 
fornix on vaginal examination using Cusco speculum. Nineteen patients (57.6%) had a 
palpable nodule in the posterior fornix and nineteen patients (57.6%) had utero-cervical 
tenderness. Utero-sacral ligaments were thickened in sixteen (48.5%), tender in 
eighteen (54.5%) and nodular in fifteen (45.5%), see table 6.  
 
 
Table 6 Clinical findings on abdominal and pelvic examination 
 
 
 
 Frequency(n) Percentage (%) 
Abdominal distension  
Abdominal tenderness    
Abdominal mass 
Pelvic Examination  
Uterus Enlarged 
Adnexal masses 
Vaginal Examination  (Speculum) 
                  Cervix Position:  Anterior 
                                               Posterior 
Lesion in the Posterior Fornix 
Digital Examination: 
                        Displaced Cervix  
                        Position: Posterior 
                        Nodule in Posterior Fornix 
Uterocervical tenderness 
 
Uterocervical Ligaments 
                                    Thickening 
                                    Tenderness 
                                    Nodularity 
 
0 
9 
7 
 
1 
5 
 
1 
32 
2 
 
0 
33 
19 
19 
 
 
16 
18 
15 
 
0 
27.3 
21.2 
 
3.0 
15.2 
 
3.0 
97.0 
6.1 
 
0.0 
100.00 
57.6 
57.6 
 
 
54.5 
54.5 
45.5 
 
Pre-operative work up: The mean haemoglobin was 12.7 g/dl, ranging from 11.0 to14.7 
g/dl. The mean CA 125 was 66.14U/ml (8-223U/ml) of which eighteen patients 
(54.6%) had a CA 125 of more than 30 U/ml.  
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Imaging: Transvaginal ultrasound detected fourteen patients (42.4%) with recto-vaginal 
nodule. Twenty one patients had a Barium enema which revealed abnormalities in three 
(15%) patients. Twenty patients had computerize tomography scan (CT) of the pelvis; 
only two (10%) of these scans revealed abnormalities in the recto-vaginal region. 
Twenty patients underwent MRI investigation of which twelve (70.59%) were reported 
to have recto-vaginal endometriosis. Fourteen patients had intravenous urography and it 
showed abnormalities (hydronephrosis) in three patients (21.4%).  (Table 7) 
 
 
Table 6. Pre-Operative work up 
  
Blood N Minimum Maximum Mean 
Hb g/dl 33 11.0 14.7 12.7 
Ca 125 U/ml 33 8 223 66.14 
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Table 7. Preoperative work-up (Imaging) 
 
 Frequency(n) Percentage (%) 
Abdominal ultrasound 
   Nil suggested recto-vaginal nodule 
Transvaginal ultrasound: Done 
                                       Suggestive 
Barium enema:             Done 
                                     Suggestive 
CT scan Pelvis             Done 
                                     Suggestive 
MRI                             Done 
                                    Suggestive 
IVU                             Done 
                                   Abnormality 
22 66.7 
 
33 
14 
 
42.4 
20 
3 
20 
2 
17 
12 
14 
3 
60.6 
15 
60.6 
10 
51.5 
70.59 
42.4 
21.4 
 
The mean operating time was one hour twenty minutes (66 min 89 minutes). Recto-
vaginal nodules and peritoneal endometriosis were identified in all patients. The 
histology specimens of all 33 patients confirmed endometriosis. Twenty eight (84.8%) 
patients had nodules of greater than 1cm. Ovarian endometriosis occurred in twenty 
four (72.7%) patients with sixteen (66.7%) having unilateral endometriomas. 
Uterosacral endometriosis was identified in eighteen (54.5%) patients and twenty one 
(63.6%) had dense adhesions during surgery (Tables 8 and 9). 
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Table 8. Disease staging at surgery 
 
Site of endometriotic nodules Frequency (n) Percentage (%) 
Peritoneal endometriosis:   Nodule size:  <1cm 
                                                           :  >1cm 
Ovarian Endometriosis 
                               Nil 
                               Unilateral 
                               Bilateral 
Deep infiltrating endometriosis 
                             Recto-vaginal 
                             Uterosacrals 
 
Adhesions:           Fine 
                           Dense 
5 15.2 
28 84.8 
 
9 
16 
8 
 
33 
18 
 
12 
21 
 
27.3 
66.7 
33.3 
 
100.0 
54.5 
 
36.4 
63.6 
 
 
Table 9. Duration of surgery 
 
 
 N Minimum Maximum Mean Std. Deviation 
Duration of surgery (Min) 33 66 121 84.9 11.23 
 
 
Intra-Operative Complications 
 
One (3%) patient required conversion from laparoscopy to laparotomy due to a rectal 
injury during operation. 
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Immediate post-Operative complications 
 
One patient had a re-laparoscopy performed 8 hours following her initial procedure 
because of suspected intra-peritoneal bleeding. Another patient was anuric for 21 hours 
post-surgery and required a cystoscopy and insertion of bilateral ureteric double j stents 
in theatre. Table 10 
 
No patients had documented post-operative pyrexia, chest infection and paralytic ileus. 
The mean post-operative haemoglobin was 12.7 g/dl (8.4 to 14.7 g/dl).  
The mean hospital stay was 5 (4 to 8) days  
 
Table 10. Surgery complications 
 
 Frequency (n) Percentage (%) 
Bowel  : Small intestine  
               Large intestine  
Urological : Bladder/ureter 
Conversion to laparotomy  
Intra-operative haemorrhage 
Re-laparoscopy  
Cystoscopy + Double J stenting 
Post-operative transfusion  
 
0 0.0 
1 3.0 
0 
1 
0 
 
1 
1 
0.0 
3.0 
0.0 
 
3.0% 
3.0% 
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Pain outcome 
 
Patients were followed in the outpatient clinic for three months post-surgery and were 
asked to compare symptoms associated with pain before and after surgery. Twenty-five 
(75.8%) patients reported improvement of pain after surgery and eight reported no 
improvement. No patient reported deterioration of pain. Twenty-three of the twenty five 
(69.7%) patients did not need adjuvant medical therapy. In total, ten (30.3%) patients 
were started on adjuvant medical therapy post-surgical intervention (Fig 6). 
There were no late complications and no readmissions.  
 
 
 
Fig 6. Pain outcome 
 
 
Adjuvant therapy 
 
In total, ten (30.3%) patients had concomitant adjuvant medical therapy post-surgery. 
Eight (80%) patients were started on GnRHa, namely Zoladex(AstraZeneca), one 
(10%) patient received Medrxoyprogesterone acetate (MDPA) namely Depo Provera 
(Pfizer) and another patient had inserted a hormonal secreting intrauterine contraceptive 
device, namely Mirena (Bayer Schering ), see table 22.  
 
 
75.8% 
24.2% 
Improvement
No Improvement
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Table 11.  Adjuvant Medical Therapy 
 
 Frequency (n) Percentage (%) 
Adjuvant therapy 
No adjuvant 
Total 
10 30.3 
23 69.7 
33 100.0 
 
 
 
Table 12 Drugs used as adjuvant therapy 
 Frequency(n) Percentage (%) 
Zoladex 
Medroxyprogesterone acetate 
Mirena 
Total 
8 80.0 
1 10 
1 10 
10 100.0 
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3.4 DISCUSSION 
 
Laparoscopic surgery with complete excision of endometriosis offers long-term pain 
relief in most women with RVE and results in a low rate of persistent or recurrent 
disease
(137)
. The prevalence of RVE in our audit was 31.4% and this is consistent with 
other studies involving tertiary referral centre for endometriosis
(86)
. Our audit has shown 
that RVE is a significant type of endometriosis being referred to the endoscopic unit. 
This is significant in that patients with this severe form of endometriosis are now being 
treated in a dedicated centre, whereas in the past we were not aware as to where they 
were being managed. 
 
The study cohort was mainly in the reproductive age group (35.4 years) and all patients 
were sexually active. This is in keeping with other studies where RVE was found 
mainly in the reproductive years
(118, 138)
. In a  study by Chapron et al., the mean age of 
patients with RVE was 29.2 years (23-47), while Fauconnier et al., reported a mean age 
of 31.1 years
(118, 139)
. In another study by Tarjanne et al., who looked specifically at 
DIE, the reported mean age was 31(20-48) years, and 136 (89.5%) patients in their 
study cohort of 153 patients were nulliparous
(138)
.  In our study, the majority were 
nulliparous (42.4%). 
 
The most prevalent racial group in this study cohort was Indians (90.9%). This could be 
explained by the fact that Indians are the predominant racial group in the Durban 
metropolitan area. Over the years, many gynaecologists believed that endometriosis 
was confined exclusively to white women
(140)
. In the early studies, the majority reported 
the prevalence of endometriosis to be doubling among white women and very rare 
among Black patients
(141-143)
. However, these studies were conducted in geographical 
areas where the population is predominantly Caucasians. More recently, there appears 
to be conflict in the different studies regarding prevalence of endometriosis in different 
the racial and ethical groups. 
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In a study of 330 women who had laparoscopic tubal ligation, Asian women had almost 
nine times greater odds of endometriosis (OR, 8.6; 95% CI, 1.4-20.1) compared with 
white patients and the findings in Blacks and Hispanics were not statistically 
different
(26)
. Several other studies also reported an increase in the prevalence of 
endometriosis among Asian women who underwent infertility evaluation or 
laparoscopy for pelvic pain compared with white women
(144, 145). In the Nurses‟ Health 
Study II, a prospective cohort study of 90,000 women, Asian women did not have a 
statistically significant difference in the odds of self-reported endometriosis in the 
model that controlled for age, parity and BMI (OR, 0.6;95% CI, 0.4-0.9). However, 
Black and Hispanic women were 40% less likely to be diagnosed with endometriosis 
(OR, 0.6; 95% CI, 0.4-1.0 for Hispanic women)
(14)
.  
 
In our audit, the most common presenting symptom was chronic pelvic pain which was 
non-cyclical and occurred in all women with RVE followed by secondary 
dysmenorrhea (93.9%), dyspareunia (57.6%) and painful defecation 36.4%.This finding 
differs with that of Griffiths et al., who reported that the most common presenting 
symptom in women with RVE was secondary dysmenorrhea (84.3%) followed by deep 
dyspareunia (47.1%) and non-cyclic chronic pelvic pain (31.4%)
(86)
. Chronic pelvic 
pain (non-cyclical) is a non-specific symptom with a variety of causes (irritable bowel, 
myofascial syndrome or psychogenic pain)
(146)
. Several other studies have assessed the 
relationship of chronic pelvic pain in patients with RVE and control patients and they 
established that chronic pelvic pain (non-cyclical) was not specific to endometriosis
(147, 
148)
. Fauconier et al., reported that when deep infiltrating endometriosis involves the 
bowel, painful defecation was higher during menstruation, which was also present in 
our study
(139)
. 
 
In our cohort, 36.4% presented with infertility. Women with endometriosis are more 
likely to have infertility problems. Angioni et al., reported a 16% incidence of infertility 
in their study of 31 patients who had DIE in the cul-de-sac, retrocervical region and in 
the recto-vaginal septum
(149)
. In a study of 500 cases with recto-vaginal nodules, 
Donnez et al., reported that 64.8% women had associated infertility
(67)
. Fauconnier et 
 54 
 
al., reported 41% incidence of infertility when looking at the relation between pain 
symptoms and the anatomic location of DIE
(139)
. Missmer et al., found that the 
prevalence of endometriosis is 20-40% in women undergoing laparoscopy for infertility 
and women with endometriosis are more likely to have fertility problems as shown in 
the study
(14)
. Although there is less agreement on the treatment of pain, most women 
with endometriosis and infertility should be referred to fertility centres of 
excellence
(150)
. 
 
Possible mechanisms that may explain the association between RVE and infertility are 
as follows:-  
 1. Adhesions may impair proper egg release from the ovary and may impair tubal 
function especially in women with advanced stages of endometriosis (stage III and IV); 
2. Peritoneal fluid in women with advanced endometriosis may inhibit sperm function 
thereby causing infertility; 
 3. Dyspareunia contributing to reduced coital frequency
(69, 151)
. Our unit is an 
endoscopy based unit receiving referrals from the Durban Metropolitan area and Kwa-
Zulu Natal province while patients with infertility problems are referred to the 
infertility unit. Hence we may not have the true incidence of endometriosis associated 
with infertility in our area. 
 
Similar to a study by Griffiths et al., patients in our cohort showed delay in seeking help 
to health professionals
(3)
. Furthermore, there was delay in clinical diagnosis of RVE. 
This could be explained by the failure of health professionals to recognize the disease 
and the inability to recognize the lesions in the posterior fornix. Many clinicians do not 
find it acceptable to examine patients during menstruation and lesions in the posterior 
fornix can easily be missed outside this period. Konninckx et al., conducted a 
prospective study in 61 women with DIE scheduled for laparoscopy and showed that 
clinical examination during menstruation can reliably diagnose RVE. In their study, 
pelvic nodularities were detected in 22 women when clinical examination was 
performed during menstruation while they were detected in only 4 women during 
routine clinical examination
(106)
.  
 55 
 
In our study, mild pelvic tenderness was detected in 27.3% of the patients and the 
uterus was enlarged in only one patient. Lesions in the posterior fornix were visualized 
in 6.1% while 57.6% had a palpable nodule in the posterior fornix. The utero-sacral 
ligaments were thickened in 48.5% with nodularity in 45.5%. Our findings appear to be 
congruent with ESHRE guidelines 2005, where it was reported that clinical signs of 
pelvic tenderness, fixed retroverted uterus, tender uterosacaral ligaments are associated 
with DIE more especially if nodules are palpable in the pouch of Douglas
(50)
. 
  
Cancer antigen 125 (CA 125) is a cell surface antigen that is expressed by derivatives of 
coelomic and mullerian epithelia. It has been established that it is elevated in many 
disease processes ranging from benign conditions to several diseases of the ovary and 
even in pregnancy
(152)
. In our cohort of patients, the mean CA 125 was 66.14 U/ml (8 to 
223 U/ml). There were 18 (54.6%) patients with elevated CA 125 (more than 30U/ml). 
In a review, serum CA125 was found not to be a good marker for diagnosing 
endometriosis but can be a helpful additional parameter to diagnose it in patients with 
chronic pelvic pain
(153)
. However, Konninckx et al., reported that CA-125 
concentrations were higher during menstruation in patients with DIE and in patients 
with deep and cystic ovarian endometriosis
(106)
. CA 125 was reported to be elevated in 
women with endometriosis stage III or IV compared to control women with normal 
pelvises [66.5 (14.5) vz. 8.2 (0.6) U/ml, mean (SEM), p<0.001] and 54% of patients 
with stage III or IV endometriosis had serum CA125 more than 35U/ml compared to 
0% in controls
(154)
. On perusal of the literature, there appears to be no study addressing 
an association of CA125 and RVE. 
 
All patients in our cohort were subjected to transvaginal ultrasound and 14(42.4%) 
patients had ultrasonographic features to support diagnosis of recto-vaginal nodule. The 
sensitivity of transvaginal ultrasound with regard to detection of recto-vaginal nodules 
is low (29.4%) in the reported literature
(155)
. The difficulty with transvaginal ultrasound 
is thought to be due to the orientation of transvaginal probes with the receiver oriented 
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toward the vaginal fornix. The ultrasound technique using the probe can be limited by 
the symphysis pubis and pain experienced by the patient when it is oriented toward the 
posterior vaginal wall during examination
(156)
. However, in a systemic review of ten 
prospective studies involving 1106 women done by Hudelist et al., the transvaginal 
sonography sensitivity for diagnosing rectosigmoid endometriosis was reported to be 
91% with specificity of 98%
(157)
. It remains the initial imaging tool due to its ready 
availability and easy access. The increase in sensitivity in our study may be due to fact 
that sonographers were requested to specifically assess for the presence of recto-vaginal 
nodules. 
 
Sonovaginography has been reported to increase the sensitivity of transvaginal 
sonography. In this procedure, the transvaginal probe is placed in the vagina after a 
saline solution has been instilled into the vagina. Bazot et al., studied 46 patients 
scheduled for resection of the clinically suspected lesions in the recto-vaginal wall and 
sonovaginography identified 91% of pathologically confirmed lesions compared with 
44% with conventional transvaginal sonography. Specificity was found to be 86% and 
50% respectively
(155)
. This technique was not practiced in our cohort of patients. 
Abdominal ultrasound was done in 22 patients (66, 7%) and it did not suggest the 
presence of RVE. This was not surprising as the abdominal ultrasound has poor 
evaluation of recto-vaginal region. Transrectal ultrasound is regarded to be the best tool 
in the diagnoses of RVE; the sensitivity is reported to be 97% and the specificity 
96%
(96)
. We did not use this technique since we did not have a dedicated transrectal 
probe.  
 
Twenty one patients had a Barium enema investigation because of lower bowel 
dysfunction and it identified abnormalities in three (15%) patients. In one patient, there 
was irregularity noted in the recto-sigmoid area, affecting the anterior wall while 
another had a focal indentation in relation to the anterior wall of the recto-vaginal 
junction. The third had a defect noted in the antero- superior rectum. Barium enema has 
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been found to have a 99% accuracy for predicting the need for intestinal surgery in a 
study conducted in 108 patients with symptoms suggestive of intestinal 
endometriosis
(103)
. Two other studies investigated the role played by double-contrast 
barium enema in recto-vaginal endometriosis and found rectal invasion in 54% and 
33%
 
respectively
(37, 158)
 . 
 
Two patients out of twenty in our cohort had abnormalities on CT scan. One patient had 
a mass measuring 2.1x1.1 cm in the pouch of Douglas and the second had a left adnexal 
mass extending to the pouch of Douglas with associated left hydronephrosis and 
hydroureter. The CT scan was done because bowel involvement was clinically 
suspected. The sensitivity of CT scan for diagnosing bowel endometriosis is reported to 
be 99% with a specificity of 100% in a single study of 98 patients
(102)
. This pick up rate 
is high because the study was looking at the endometriosis of the large bowel whereas 
our study was looking specifically for RVE. 
 
Magnetic Resonance Imaging (MRI) is the best imaging tool to diagnose RVE
(92)
. It 
provides information on location, extension and infiltration of the vagina or rectum but 
fibrosis in the endometrium can change the signal intensity pattern causing motion 
artifacts on bowel peristalsis
(91)
. Bazot et al., reported the sensitivity of MRI to be 80% 
and specificity of 93% from 15 patients with recto-vaginal endometriosis
(155)
. In our 
study, MRI was done in selected patients to define the extent of the nodule and it had a 
high pick up rate as reported in literature. It identified recto-vaginal nodule in twelve 
(70.59%) out of seventeen patients done.  
 
Fourteen patients had intravenous urography (IVU) and abnormality (hydronephrosis) 
was identified in three patients (21.4%). Large recto-vaginal nodules are known to have 
a mass effect on the ureters and can cause hydronephrosis
(159)
.  In a study by Donnez et 
al., involving 500 patients with RVE, IVU identified 18 (4.4%) patients with stricture of 
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the lowest portion of the ureter causing moderate to severe hydronephrosis. In their 
study, seventeen patients had unilateral stenosis in which 7 patients had right side 
ureterohydronephrosis and 10 patients had left side ureterohydronephosis. One patient 
had bilateral ureterohydronephrosis
(159)
.  
 
In our study, all surgery was performed by a single surgeon who is the head of 
gynecological endoscopy unit at IALCH. The Harmonic scalpel was used in all 
patients. The instrument is designed to cut and coagulate tissues. It allows for excellent 
coagulation and cutting and also facilitates dissection. It works at a relatively low 
temperature, thus reducing thermal injury and allows rapid tissue healing.  This 
instrument has no electrical current passing through the patient, hence electrical injuries 
are avoided
(131)
. Robbins operated on 14 women for peritoneal endometriosis using 
Harmonic scalpel. All women had uneventful post-operative recovery. Thirteen were 
discharged on the same day, while the other had post-operative bowel care after 
resection and repair of an endometriotic lesion on the anterior rectal wall and was 
discharged on day 4 post-operatively
(160)
. Ford et al., reported on one patient operated 
for recto-vaginal endometriosis using same tool. The patient had an uneventful post-
operative course and patient was discharged on day 5 post-operatively
(161)
.  
 
In our audit, the mean operating time (excluding anaesthetic time) was 84.9 minutes 
(66-129) minutes. Donnez et al., reported a mean duration of 64 (45-120) minutes in 
231 patients operated for RVE and Tarjanne el al. reported 100 (20-300) minutes when 
bowel resection was not done
(107, 138)
. Harmonic scalpel was used in both surgeries. 
 
All the patients in our study had associated peritoneal endometriosis. In a study of 153 
patients with RVE by Tarjanne et al., peritoneal endometriosis was present in 69 (45%) 
patients
(138)
. Peritoneal endometriosis is often commonly found either alone or in 
association with other types of endometriosis. This is despite the fact that peritoneal 
endometriosis is reported to originate from „retrograde menstruation‟ while RVE 
originates from coelomic metaplasia
(22) (41)
. However, Vercellini et al., indicate that 
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RVE may be a different manifestation of endometriosis with a single origin i.e. 
regurgitated endometrial cells
(48)
. 
 
In our study cohort, twenty-eight (84.8%) patients had nodules of greater than 1cm and 
fifteen of the 28(53%) patients had severe symptoms of the disease. On literature 
perusal, endometriotic nodules vary in size from a few millimeters to 2cm in diameter. 
The amount of pigment in the nodule appears to increase with the age of the lesion. 
Initially these lesions appear as white plaques, non-pigmented clear vesicles or red 
petechia/ or flame-like areas and they change to bluish/brownish colour as they age 
because of haemolysed blood encased in fibrotic tissue
(162)
. The type and severity of 
symptoms is related to the depth of endometriotic infiltration and size of the nodule
(162)
. 
 
Ovarian endometriosis occurred in twenty-four patients (72.7%) with sixteen patients 
(66.7%) having unilateral endometriomas and 10 patients had left ovarian 
endometriosis in our study cohort. This finding is in keeping with Redwine‟s findings 
that left ovarian endometriosis is more common than right ovarian endometriosis
(163)
. In 
a study of 515 patients with endometriosis by Al-Fazan et al., ovarian endometriosis 
was encountered in 185 patients and left endometrioma occurred more frequently 
(60.4%) (p<0.001, OR 2.3, 95% CI 1.5-3.7)
(164)
.  
 
In our audit, there was no post-operative fever, wound infection or bowel ileus. Angioni 
et al., reported fever of >38
0
C after two days post-surgery in 2/31 patients
(149)
. The 
complications from usage of harmonic scalpel in our study was comparable to those 
reported by other authors using other energy sources, namely, electro-surgery 
(monopolar and bilpolar) and Carbon Dioxide laser
(67, 118)
. 
 
There were 3 women in our study with major complications requiring surgical 
intervention. The first patient required conversion from laparoscopy to laparotomy due 
to a rectal injury. During surgery, following excision of recto-vaginal nodule, a defect 
in the rectal wall was identified. The decision to convert to laparotomy was made by a 
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surgeon. Primary repair of the bowel was performed and the patient had uneventful 
recovery.  
 
The second patient required re-laparoscopy for bleeding in the post-operative period. 
This patient had undergone bilateral ovarian cystectomies and removal of a recto-
vaginal nodule. Post operatively, she complained of increasing abdominal pain which 
was associated with tachycardia and there was a drop in the haemoglobin levels from 
11.5 g/dl pre-operatively to 8.4 g/dl post-operatively. The patient had a blood 
transfusion and re-laparoscopy was performed. Minor oozing was identified at the 
hilum of the ovary. Coagulation was achieved with bipolar diathermy and a copious 
washout was performed and patient recovered well. 
 
The last patient had extensive bilateral ureterolysis at surgery and resection of both 
uterosacrals and large recto-vaginal nodules was done. Ureteric stents were not used 
intra-operatively. Post-surgery, the patient was anuric for 21 hours despite being 
catheterized with a Foley‟s catheter. Changing of the Foley‟s catheter and a fluid 
challenge yielded no positive results. Urea was slightly elevated (7.5mmol/l) and an 
ultrasound revealed no fluid collection in the pelvis and there was no significant 
hydroureter or hydronephrosis. An urgent CT-IVP with delayed imaging was performed 
and showed poor enhancement of both kidneys. There was delayed excretion noted with 
filling of the left pelvic caleceal system only noted on the 35 minute delayed film. Both 
ureters were dilated up to the level of the pelvis. The conclusion was that there was 
acute bilateral obstructive uropathy which may be due to oedema, inflammatory change 
or bilateral ureteric spasms. The exact point of obstruction could not be determined. 
The patient was taken to theatre, cystoscopy was performed and double J ureteric stents 
were inserted. The patient started to pass copious amounts of urine immediately 
following insertion of the stents and passed volume of 2 litres in the next 3 hours. The 
patient recovered well and was discharged on day 4. The ureteric stents were removed 
at the out-patient clinic 2 weeks post-surgery. Ureteral spasms following surgery was 
the only explanation for the anuria and no other study could be found in the literature 
addressing this complication. 
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None of our patients underwent bowel resection, no thermal injury to the bowel or 
ureters and no patient developed recto-vaginal fistula, bladder or vascular injuries in our 
study. This could be because Harmonic scalpel was the primary energy source for 
dissection and coagulation. 
 
Several studies have assessed outcomes and complications of conservative surgery for 
RVE. All have reported low major complication rates. Chapron et al., conducted a study 
on 29 patients with DIE invading the recto-vaginal septum using the laparoscopic 
assisted vaginal approach. The major complications were 3.5% (one patient developed 
recto-vaginal fistula) and the surgeries were carried out laparoscopically and the 
laparoscopic scissors were used for dissection and bipolar coagulation used for 
haemostasis
(118)
. In another recent study by Donnez el al., using the CO2 laser, major 
complications in their study of 500 patients with RVE included: 1.4% rectal 
perforation, 0.8% ureteral injury, blood loss of > 300ml in 0.2% and urinary retention in 
0.8%. There were no conversions to laparotomy carried out
(67)
. In a recent study by 
Maytham et al., major complications were reported to be 7% of which 4% required re-
operation
(165)
. 
 
In another study by Meuleman et al., 11% of women had severe complications, One of 
the complications, namely lower leg compartment syndrome occurred (3/56) and  this 
was explained on the bases of long duration of operation with a mean duration of 
surgery of 7 hours
(166)
. 
 
The mean duration of hospital stay was 4 days (3 to 6). Chapron et al., reported the 
mean duration of hospital stay of 3.5 ± 1.3 days (range 2-9)
(118)
. In another study by 
Tarjanne et al., the reported mean duration of hospital stay was 2 (1-12) days for 
patients who had no bowel resection done and 5(3-12) days for patients who had bowel 
resection done
(138)
. With advanced laparoscopy especially with operation at close 
proximity to the rectum, it is advisable that these patients be observed post-surgery. 
Injury to the bowel may show delay in clinical manifestation and our patients are 
normally kept in for a minimum of 3 days post-surgery. 
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Twenty-three (69.7%) patients reported improvement in pain and quality of life and did 
not need adjuvant therapy. Two out of twenty-five (6%) reported some improvement 
but needed adjuvant medical therapy because of the fear of the previous pain experience 
and 8/33 (24.2%) patients reported no change to their symptoms. These findings are in 
keeping with other studies, namely, Chapron et al., reported an improvement in chronic 
pelvic pain of 92.9% with 85.8% described as excellent and 7.1% described as 
satisfactory after one year of follow up following surgery and  Angioni et al., reported 
60% improvement in chronic pelvic pain after a five year follow up following 
surgery
(118, 149)
. 
 
In total, 10/33 (30.3%) patients in our audit had concomitant medical therapy. At the 
end of 3 months, only 3 patients on concomitant adjuvant medical therapy reported 
improvement of symptoms
(110)
. This was not surprising because according to Vercellin 
et al., hormonal therapy for RVE only induces temporary quiescence of active foci but 
do not cure the disease
(110)
. However, women who do not want to be subjected to 
surgery again may prefer medical therapy if surgery did not help to alleviate pain 
symptoms. Vercerllin et al., reported that low-dose Norethindrone acetate could be 
considered as an alternative to repeat surgery for symptomatic women with recto-
vaginal lesions and who don‟t want to conceive. According to their study, 73% women 
were satisfied with the treatment compared to 62% who were on Ethenyl E2 plus 
Cyproterone Acetate after 12 months follow up
(167)
. 
 
There were limitations to our study. Firstly, it is a retrospective study. Secondly, the 
assessment of pain and quality of life issues were not standardized and formally 
assessed using validated questionnaire. This might lead to uncertainty regarding the 
parameters used to describe pain symptoms as was based on documentation by 
individual physicians from patient description of pain before and after surgery. The 
third limitation was that there was short duration of follow up. In the unit, once patients 
showed improvement in the symptomatology, they are referred to the base hospital for 
further follow up and it would have been difficult to get the records of these patients. 
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The fourth limitation was that fertility outcome could not be assessed as we do not have 
an established assisted reproductive unit. 
 
 
3.5  Recommendations and Conclusion 
 
Careful examination of the patient with RVE, with particular attention to the posterior 
fornix, can pick up significant number of patients with RVE more especially during 
menstruation. The MRI pelvis can be regarded as the best imaging tool in detecting 
RVE as shown in our results and in the reported literature but it must be noted that its 
sensitivity is dependent on the its operator. Patients with RVE should be managed in the 
dedicated center where laparoscopic surgical excision can be done and where the 
specialized multi-disciplinary team (surgeons, colorectal and specialized radiologists) is 
readily available. This reduces the possible complications as shown in the study. 
Further studies to assess shaving, bowel resection and discoid excision using Harmonic 
scalpel should be undertaken and may be of value in assessing the ideal surgical 
approach for RVE. 
 
 
Conclusion 
 
 
The usage of Harmonic scalpel as the energy source in the surgical management of 
RVE appears to be safe. Our findings are similar to that in the published literature using 
other energy sources for the surgical management of RVE.  
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Structured Data Capture Sheet 
 
Study No     
Age (years)  
Parity  
Racial group:                       African                =1 
                                           Indian                 =2 
                                           Coloured             =3 
                                           White                  =4 
 
 
Referred from:                     Private                   = 1 
                                               Semi-Private       = 2 
                                               District Hospital   =  3   
                                               Regional             =  4                                                                     
 
Specify how dx was made:  Not made            =0                      
                                          Clinical                =1 
                                          Sonar                  =2 
                                          MRI                     =3 
                                          CT Pelvis             =4 
                                          Laparoscopic       =5 
 
 
   
 
 
Presenting Complaint:        Chronic Pelvic pain         Y=1, N=2 
                                                Dysmenorrhea                 Y=1, N=2 
                                                Dyspareunia: Superficial  Y=1, N=2 
                                                                       Deep          Y=1, N=2 
 
 
 
 
 
 
Defecatory symptoms:    Dyschezia                     Y=1, N=2 
                                     Painful defecation           Y=1, N=2 
                                     Rectal bleeding               Y=1, N=2 
                                     Irritable bowel                 Y=1, N=2 
 
 
 
 
 
  
 
Duration of Symptoms in (months):      < 3   =1 
                                                              4-6   = 2 
                                                              7-12 = 3 
                                                             13 or more =4 
 
Duration between symptoms and   :    within 1 =1 
1st visit to health professional(years)    1  to  2  =2    
                                                              >  2      =3  
 
                  
1st visit to Health Professional:                 GP            =1 
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                                                                  Hospital   =2 
                                                                  Specialist   3 
 
 
 
 
Duration from 1st visit to HP to clinical dx of RVE (months)                     
 
  
 
Infertility :                                            Y=1, N=2    
 
 
 
If infertility, duration ( years)       
 
  
 
PPrevious Gynaecological  operation    Y=1, N=2 
 
 
 
If yes, Specify: Laparoscopy =1                 
            Laparotomy   =2 
 
 
Duration between 1st visit to IALCH and Surgical intervention 
(weeks)  
 
 
 
   
Examination:       Weight  Height  BMI   
                          Anemia                         Yes=1, N=2 
                          Abdominal distension     Yes=1, N=2 
                          Abdominal tenderness    Yes=1, N=2 
                          Abdominal masses         Yes=1, N=2 
 
 
 
 
  
Pelvic Examination: Uterus enlarged       Yes=1, N=2 
                                    Adnexal masses       Yes=1, N=2 
 
  
 
Vaginal examination (speculum): Cervix position: Anterior=1, posterior=2, 
central=3 
                                                       Lesion on posterior fornix      Yes=1, N=2 
 
 
 
 
Uterosacral ligaments:   Thickening     Yes=1, N=2  
                                        Tenderness     Yes=1, N=2 
                                        Nodularity      Yes=1, N=2 
  
 
 
 
 
 
 
Pre-operative work up 
Hb  Barium meal:  
 
Hct  CT Pelvis:  
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Ca125   MRI:  
 
 
 
Sonar: 
Abdominal  IVP:  
 Transvaginal 
 
 
Referral to other disciplines   Yes=1, N=2 
                         If yes             Specify 
 
                  
                         State reason: 
 
   
 
 
 
 
 
  
Duration from 1st visit at IALCH to time of initial surgery 
(days)   
 
 
  
 
Surgery Details 
 
 
Energy Source :           
 
 
Duration of Operation(min) 
 
 
Staging    
     at 
 Surgery 
Korninceky 
Classification 
Peritoneal Endometriosis <1cm > 1cm 
 
Ovarian Endometriosis 
 
 
Unilateral:  
 
Bilateral 
Deep Endometriosis Recto-vaginal 
        
 
Uterosacrals 
       
Extra-peritoneal 
 
Presence of adhesions 
 
Y N Dense  
Light  
 
 
 
 
 
 
 
 
Intra-operative 
Complications 
  
 
 
Bowel injury 
 
Small 
 
 
Management 
 
Large 
 
 
  
 
Urological 
 
Bladder 
 
 
?Any Conversion to Laparotomy 
 
Ureter 
 
 
 Hemorrhage 
 
Y 
 
N If yes  transfusion, how many 
units 
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Immediate Post-Operative Complications   
     Infections- Pyrexia (2 consecutive Temps of 38 or more):  Yes=1, N=2 
     Wound infection                                                                  Yes=1, n=2 
     Urinary tract infection                                                          Yes=1, n=2 
     Chest Infection                                                                    Yes=1, n=2 
     Bowel- ileus                                                                        Yes=1, N=2 
 
 
 
 
 
Anaemia Hb Any blood transfusion Yes No If Yes, how many 
units 
 
Other: Thrombo-embolism Yes No Re-laparotomy Yes no 
 
Re-Operation:  
 
Re-laparotomy  
Re-Laparoscopy  
Yes=1, n=2 
Yes=1, N=2 
 
 
 
Other, specify 
 
Period from date of initial Surgery at IALCH    
to most recent visit to IALCH, specify                              
 
 
 
 
